WO2000056905A2 - Procede pour accelerer et/ou ameliorer la croissance et/ou le rendement de vegetaux ou pour modifier leur architecture - Google Patents
Procede pour accelerer et/ou ameliorer la croissance et/ou le rendement de vegetaux ou pour modifier leur architecture Download PDFInfo
- Publication number
- WO2000056905A2 WO2000056905A2 PCT/EP2000/002441 EP0002441W WO0056905A2 WO 2000056905 A2 WO2000056905 A2 WO 2000056905A2 EP 0002441 W EP0002441 W EP 0002441W WO 0056905 A2 WO0056905 A2 WO 0056905A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plant
- cyclin
- cdk
- cell cycle
- nucleic acid
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 97
- 230000008635 plant growth Effects 0.000 title claims abstract description 31
- 230000002708 enhancing effect Effects 0.000 title description 3
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 168
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 130
- 230000022131 cell cycle Effects 0.000 claims abstract description 114
- 230000012010 growth Effects 0.000 claims abstract description 77
- 108050006400 Cyclin Proteins 0.000 claims abstract description 76
- 102000016736 Cyclin Human genes 0.000 claims abstract description 74
- 230000014509 gene expression Effects 0.000 claims abstract description 49
- 230000001965 increasing effect Effects 0.000 claims abstract description 41
- 230000009261 transgenic effect Effects 0.000 claims abstract description 37
- 230000032823 cell division Effects 0.000 claims abstract description 21
- 238000004519 manufacturing process Methods 0.000 claims abstract description 20
- 108060006633 protein kinase Proteins 0.000 claims abstract description 20
- 102000001253 Protein Kinase Human genes 0.000 claims abstract description 19
- 239000002028 Biomass Substances 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims abstract description 10
- 239000000654 additive Substances 0.000 claims abstract description 5
- 238000012258 culturing Methods 0.000 claims abstract description 5
- 229930000044 secondary metabolite Natural products 0.000 claims abstract description 5
- 241000196324 Embryophyta Species 0.000 claims description 250
- 239000013598 vector Substances 0.000 claims description 83
- 108020004707 nucleic acids Proteins 0.000 claims description 71
- 102000039446 nucleic acids Human genes 0.000 claims description 71
- 150000007523 nucleic acids Chemical class 0.000 claims description 71
- 230000001105 regulatory effect Effects 0.000 claims description 46
- 210000000056 organ Anatomy 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 15
- 230000002786 root growth Effects 0.000 claims description 14
- 101150012716 CDK1 gene Proteins 0.000 claims description 13
- 240000007594 Oryza sativa Species 0.000 claims description 12
- 235000013399 edible fruits Nutrition 0.000 claims description 12
- 108091000080 Phosphotransferase Proteins 0.000 claims description 11
- 102000020233 phosphotransferase Human genes 0.000 claims description 11
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 10
- 235000007164 Oryza sativa Nutrition 0.000 claims description 10
- 235000009566 rice Nutrition 0.000 claims description 10
- 102000005483 Cell Cycle Proteins Human genes 0.000 claims description 9
- 108010031896 Cell Cycle Proteins Proteins 0.000 claims description 9
- 230000000977 initiatory effect Effects 0.000 claims description 9
- 230000000638 stimulation Effects 0.000 claims description 9
- 235000013339 cereals Nutrition 0.000 claims description 8
- 101000721172 Homo sapiens Protein DBF4 homolog A Proteins 0.000 claims description 7
- 108010067244 Origin Recognition Complex Proteins 0.000 claims description 7
- 102100040591 Origin recognition complex subunit 1 Human genes 0.000 claims description 7
- 102100025198 Protein DBF4 homolog A Human genes 0.000 claims description 7
- 240000008042 Zea mays Species 0.000 claims description 7
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 7
- 230000015572 biosynthetic process Effects 0.000 claims description 7
- 230000001939 inductive effect Effects 0.000 claims description 7
- 239000002023 wood Substances 0.000 claims description 7
- 102100027047 Cell division control protein 6 homolog Human genes 0.000 claims description 6
- 102100034744 Cell division cycle 7-related protein kinase Human genes 0.000 claims description 6
- 101000914465 Homo sapiens Cell division control protein 6 homolog Proteins 0.000 claims description 6
- 101000945740 Homo sapiens Cell division cycle 7-related protein kinase Proteins 0.000 claims description 6
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 6
- 230000001419 dependent effect Effects 0.000 claims description 6
- 239000003623 enhancer Substances 0.000 claims description 6
- 235000009973 maize Nutrition 0.000 claims description 6
- 238000004113 cell culture Methods 0.000 claims description 5
- 235000006008 Brassica napus var napus Nutrition 0.000 claims description 4
- 240000007124 Brassica oleracea Species 0.000 claims description 4
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims description 4
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims description 4
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 claims description 4
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims description 4
- 229920000742 Cotton Polymers 0.000 claims description 4
- 235000002767 Daucus carota Nutrition 0.000 claims description 4
- 244000000626 Daucus carota Species 0.000 claims description 4
- 230000003197 catalytic effect Effects 0.000 claims description 4
- 244000038559 crop plants Species 0.000 claims description 4
- 238000011161 development Methods 0.000 claims description 4
- 230000005764 inhibitory process Effects 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 108020005345 3' Untranslated Regions Proteins 0.000 claims description 3
- 108020003589 5' Untranslated Regions Proteins 0.000 claims description 3
- 101000737234 Arabidopsis thaliana Cyclin-A2-2 Proteins 0.000 claims description 3
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 claims description 3
- 101710183319 Cyclin-B2-2 Proteins 0.000 claims description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 3
- 240000005979 Hordeum vulgare Species 0.000 claims description 3
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 3
- 240000003183 Manihot esculenta Species 0.000 claims description 3
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims description 3
- 240000003768 Solanum lycopersicum Species 0.000 claims description 3
- 244000061456 Solanum tuberosum Species 0.000 claims description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 3
- 235000021536 Sugar beet Nutrition 0.000 claims description 3
- 235000021307 Triticum Nutrition 0.000 claims description 3
- 244000098338 Triticum aestivum Species 0.000 claims description 3
- 238000000338 in vitro Methods 0.000 claims description 3
- 238000001727 in vivo Methods 0.000 claims description 3
- 230000008117 seed development Effects 0.000 claims description 3
- 230000003584 silencer Effects 0.000 claims description 3
- 230000000087 stabilizing effect Effects 0.000 claims description 3
- 240000004507 Abelmoschus esculentus Species 0.000 claims description 2
- 244000291564 Allium cepa Species 0.000 claims description 2
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims description 2
- 240000007087 Apium graveolens Species 0.000 claims description 2
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 claims description 2
- 235000010591 Appio Nutrition 0.000 claims description 2
- 244000003416 Asparagus officinalis Species 0.000 claims description 2
- 235000005340 Asparagus officinalis Nutrition 0.000 claims description 2
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 claims description 2
- 240000002791 Brassica napus Species 0.000 claims description 2
- 240000000385 Brassica napus var. napus Species 0.000 claims description 2
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims description 2
- 235000004221 Brassica oleracea var gemmifera Nutrition 0.000 claims description 2
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims description 2
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims description 2
- 244000064816 Brassica oleracea var. acephala Species 0.000 claims description 2
- 244000308368 Brassica oleracea var. gemmifera Species 0.000 claims description 2
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 claims description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims description 2
- 235000009854 Cucurbita moschata Nutrition 0.000 claims description 2
- 240000001980 Cucurbita pepo Species 0.000 claims description 2
- 235000009852 Cucurbita pepo Nutrition 0.000 claims description 2
- 244000019459 Cynara cardunculus Species 0.000 claims description 2
- 235000019106 Cynara scolymus Nutrition 0.000 claims description 2
- 244000068988 Glycine max Species 0.000 claims description 2
- 235000010469 Glycine max Nutrition 0.000 claims description 2
- 241000219146 Gossypium Species 0.000 claims description 2
- 244000020551 Helianthus annuus Species 0.000 claims description 2
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 2
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 claims description 2
- 244000043158 Lens esculenta Species 0.000 claims description 2
- 235000004431 Linum usitatissimum Nutrition 0.000 claims description 2
- 240000006240 Linum usitatissimum Species 0.000 claims description 2
- 240000000111 Saccharum officinarum Species 0.000 claims description 2
- 235000007201 Saccharum officinarum Nutrition 0.000 claims description 2
- 244000269722 Thea sinensis Species 0.000 claims description 2
- 241000219094 Vitaceae Species 0.000 claims description 2
- 235000016520 artichoke thistle Nutrition 0.000 claims description 2
- 230000018109 developmental process Effects 0.000 claims description 2
- 239000004459 forage Substances 0.000 claims description 2
- 235000021021 grapes Nutrition 0.000 claims description 2
- 235000021384 green leafy vegetables Nutrition 0.000 claims description 2
- 235000021374 legumes Nutrition 0.000 claims description 2
- 235000020354 squash Nutrition 0.000 claims description 2
- 235000013616 tea Nutrition 0.000 claims description 2
- 101710123452 Cyclin-D4-1 Proteins 0.000 claims 4
- 101000737249 Arabidopsis thaliana Cyclin-A2-3 Proteins 0.000 claims 2
- 101710172756 Cyclin-A2-1 Proteins 0.000 claims 2
- 101710183326 Cyclin-B2-1 Proteins 0.000 claims 2
- 101710144581 Cyclin-D2-1 Proteins 0.000 claims 2
- 101710144958 Cyclin-D3-1 Proteins 0.000 claims 2
- 101000737243 Arabidopsis thaliana Putative cyclin-A3-1 Proteins 0.000 claims 1
- 101000737244 Oryza sativa subsp. japonica Cyclin-A3-1 Proteins 0.000 claims 1
- 230000002452 interceptive effect Effects 0.000 claims 1
- JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 210000004027 cell Anatomy 0.000 description 123
- 235000018102 proteins Nutrition 0.000 description 107
- 108090000266 Cyclin-dependent kinases Proteins 0.000 description 76
- 102000003903 Cyclin-dependent kinases Human genes 0.000 description 76
- 210000001519 tissue Anatomy 0.000 description 41
- 108090000765 processed proteins & peptides Proteins 0.000 description 29
- 108091007914 CDKs Proteins 0.000 description 26
- 230000000694 effects Effects 0.000 description 26
- 230000002018 overexpression Effects 0.000 description 25
- 102000004196 processed proteins & peptides Human genes 0.000 description 24
- 101000797714 Oryza sativa subsp. japonica Cyclin-B1-3 Proteins 0.000 description 23
- 230000009466 transformation Effects 0.000 description 21
- 101100273648 Mus musculus Ccna2 gene Proteins 0.000 description 19
- 229920001184 polypeptide Polymers 0.000 description 19
- 101100059444 Mus musculus Ccnb1 gene Proteins 0.000 description 17
- 235000001014 amino acid Nutrition 0.000 description 16
- 108020004414 DNA Proteins 0.000 description 13
- 230000004927 fusion Effects 0.000 description 13
- 150000001413 amino acids Chemical class 0.000 description 12
- 230000004048 modification Effects 0.000 description 12
- 238000012986 modification Methods 0.000 description 12
- HVLSXIKZNLPZJJ-TXZCQADKSA-N HA peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 HVLSXIKZNLPZJJ-TXZCQADKSA-N 0.000 description 11
- 239000000872 buffer Substances 0.000 description 10
- 239000012634 fragment Substances 0.000 description 10
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 9
- 241000219194 Arabidopsis Species 0.000 description 9
- 108020004635 Complementary DNA Proteins 0.000 description 9
- 230000010337 G2 phase Effects 0.000 description 9
- 101100327152 Oryza sativa subsp. japonica CYCB2-1 gene Proteins 0.000 description 9
- 101100327155 Oryza sativa subsp. japonica CYCB2-2 gene Proteins 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 125000003275 alpha amino acid group Chemical group 0.000 description 9
- 101150014506 ccnb2 gene Proteins 0.000 description 9
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 8
- 108091026890 Coding region Proteins 0.000 description 8
- 230000010190 G1 phase Effects 0.000 description 8
- 230000018199 S phase Effects 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 230000005014 ectopic expression Effects 0.000 description 8
- 239000003550 marker Substances 0.000 description 8
- 239000013612 plasmid Substances 0.000 description 8
- 241000589158 Agrobacterium Species 0.000 description 7
- 108700019146 Transgenes Proteins 0.000 description 7
- 239000002299 complementary DNA Substances 0.000 description 7
- 230000001054 cortical effect Effects 0.000 description 7
- 230000035784 germination Effects 0.000 description 7
- 230000001404 mediated effect Effects 0.000 description 7
- 108020004999 messenger RNA Proteins 0.000 description 7
- 230000007704 transition Effects 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 description 6
- 210000001161 mammalian embryo Anatomy 0.000 description 6
- 230000000394 mitotic effect Effects 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 238000006467 substitution reaction Methods 0.000 description 6
- 230000002103 transcriptional effect Effects 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 101000737812 Arabidopsis thaliana Cyclin-dependent kinase A-1 Proteins 0.000 description 5
- 241000701489 Cauliflower mosaic virus Species 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 210000003527 eukaryotic cell Anatomy 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000003780 insertion Methods 0.000 description 5
- 230000037431 insertion Effects 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 230000000670 limiting effect Effects 0.000 description 5
- 230000011278 mitosis Effects 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 125000003729 nucleotide group Chemical group 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 238000003752 polymerase chain reaction Methods 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000035882 stress Effects 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 108700028369 Alleles Proteins 0.000 description 4
- 241000219195 Arabidopsis thaliana Species 0.000 description 4
- 108090000259 Cyclin D Proteins 0.000 description 4
- DHCLVCXQIBBOPH-UHFFFAOYSA-N Glycerol 2-phosphate Chemical compound OCC(CO)OP(O)(O)=O DHCLVCXQIBBOPH-UHFFFAOYSA-N 0.000 description 4
- 230000027311 M phase Effects 0.000 description 4
- 108010085220 Multiprotein Complexes Proteins 0.000 description 4
- 102000007474 Multiprotein Complexes Human genes 0.000 description 4
- 244000061176 Nicotiana tabacum Species 0.000 description 4
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 108010050181 aleurone Proteins 0.000 description 4
- 230000003466 anti-cipated effect Effects 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 4
- 239000004062 cytokinin Substances 0.000 description 4
- 230000006353 environmental stress Effects 0.000 description 4
- 108091006104 gene-regulatory proteins Proteins 0.000 description 4
- 102000034356 gene-regulatory proteins Human genes 0.000 description 4
- 239000011539 homogenization buffer Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 230000026731 phosphorylation Effects 0.000 description 4
- 238000006366 phosphorylation reaction Methods 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 230000004936 stimulating effect Effects 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
- 102000003910 Cyclin D Human genes 0.000 description 3
- 102100025191 Cyclin-A2 Human genes 0.000 description 3
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 3
- 230000004543 DNA replication Effects 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 230000020172 G2/M transition checkpoint Effects 0.000 description 3
- 241000219823 Medicago Species 0.000 description 3
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 3
- 108091023040 Transcription factor Proteins 0.000 description 3
- 108090000848 Ubiquitin Proteins 0.000 description 3
- 102000044159 Ubiquitin Human genes 0.000 description 3
- 230000001133 acceleration Effects 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 230000004186 co-expression Effects 0.000 description 3
- 238000004520 electroporation Methods 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 230000008121 plant development Effects 0.000 description 3
- 108091033319 polynucleotide Proteins 0.000 description 3
- 102000040430 polynucleotide Human genes 0.000 description 3
- 239000002157 polynucleotide Substances 0.000 description 3
- 210000001236 prokaryotic cell Anatomy 0.000 description 3
- 210000001938 protoplast Anatomy 0.000 description 3
- 230000022983 regulation of cell cycle Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000009331 sowing Methods 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 2
- 101100219872 Arabidopsis thaliana CYCD1-1 gene Proteins 0.000 description 2
- 101100273515 Arabidopsis thaliana CYCD2-1 gene Proteins 0.000 description 2
- 101100059375 Arabidopsis thaliana CYCD3-1 gene Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 108010060273 Cyclin A2 Proteins 0.000 description 2
- 108010058544 Cyclin D2 Proteins 0.000 description 2
- 101710184071 Cyclin-B1-1 Proteins 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 101100382951 Danio rerio ccnd1 gene Proteins 0.000 description 2
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 2
- 102100024185 G1/S-specific cyclin-D2 Human genes 0.000 description 2
- 229930191978 Gibberellin Natural products 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 108010038807 Oligopeptides Proteins 0.000 description 2
- 102000015636 Oligopeptides Human genes 0.000 description 2
- 102000052812 Ornithine decarboxylases Human genes 0.000 description 2
- 108700005126 Ornithine decarboxylases Proteins 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 2
- 108010076504 Protein Sorting Signals Proteins 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 102000040945 Transcription factor Human genes 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 108700021031 cdc Genes Proteins 0.000 description 2
- 230000018486 cell cycle phase Effects 0.000 description 2
- 230000006369 cell cycle progression Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000009918 complex formation Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 230000021953 cytokinesis Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 230000030609 dephosphorylation Effects 0.000 description 2
- 238000006209 dephosphorylation reaction Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 2
- 239000003448 gibberellin Substances 0.000 description 2
- 238000013537 high throughput screening Methods 0.000 description 2
- 108010052344 histone H1 kinase Proteins 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 230000002015 leaf growth Effects 0.000 description 2
- 230000000442 meristematic effect Effects 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 229940079938 nitrocellulose Drugs 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- -1 oiigope'ptides Proteins 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 238000004161 plant tissue culture Methods 0.000 description 2
- 230000004481 post-translational protein modification Effects 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 238000004382 potting Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000005204 segregation Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- CXNPLSGKWMLZPZ-GIFSMMMISA-N (2r,3r,6s)-3-[[(3s)-3-amino-5-[carbamimidoyl(methyl)amino]pentanoyl]amino]-6-(4-amino-2-oxopyrimidin-1-yl)-3,6-dihydro-2h-pyran-2-carboxylic acid Chemical compound O1[C@@H](C(O)=O)[C@H](NC(=O)C[C@@H](N)CCN(C)C(N)=N)C=C[C@H]1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-GIFSMMMISA-N 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 101100112869 Arabidopsis thaliana CDKA-1 gene Proteins 0.000 description 1
- 241001465318 Aspergillus terreus Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 101150116799 CDC2A gene Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108010068192 Cyclin A Proteins 0.000 description 1
- 108010068150 Cyclin B Proteins 0.000 description 1
- 102000002427 Cyclin B Human genes 0.000 description 1
- 108010068155 Cyclin C Proteins 0.000 description 1
- 102000002428 Cyclin C Human genes 0.000 description 1
- 108050001682 Cyclin-like Proteins 0.000 description 1
- 102000011376 Cyclin-like Human genes 0.000 description 1
- IMXSCCDUAFEIOE-UHFFFAOYSA-N D-Octopin Natural products OC(=O)C(C)NC(C(O)=O)CCCN=C(N)N IMXSCCDUAFEIOE-UHFFFAOYSA-N 0.000 description 1
- IMXSCCDUAFEIOE-RITPCOANSA-N D-octopine Chemical compound [O-]C(=O)[C@@H](C)[NH2+][C@H](C([O-])=O)CCCNC(N)=[NH2+] IMXSCCDUAFEIOE-RITPCOANSA-N 0.000 description 1
- 229920002271 DEAE-Sepharose Polymers 0.000 description 1
- 101150074155 DHFR gene Proteins 0.000 description 1
- 102100024829 DNA polymerase delta catalytic subunit Human genes 0.000 description 1
- 241001534909 Dirca palustris Species 0.000 description 1
- 101100136092 Drosophila melanogaster peng gene Proteins 0.000 description 1
- 241000698776 Duma Species 0.000 description 1
- 101100059559 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) nimX gene Proteins 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 230000004707 G1/S transition Effects 0.000 description 1
- 230000008051 G1/S transition checkpoint Effects 0.000 description 1
- 101100273645 Gallus gallus CCNA2 gene Proteins 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 102000006947 Histones Human genes 0.000 description 1
- 101000934320 Homo sapiens Cyclin-A2 Proteins 0.000 description 1
- 101000868333 Homo sapiens Cyclin-dependent kinase 1 Proteins 0.000 description 1
- 101000909198 Homo sapiens DNA polymerase delta catalytic subunit Proteins 0.000 description 1
- 101000624643 Homo sapiens M-phase inducer phosphatase 3 Proteins 0.000 description 1
- 101000580039 Homo sapiens Ras-specific guanine nucleotide-releasing factor 1 Proteins 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 241000219739 Lens Species 0.000 description 1
- GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 102100023330 M-phase inducer phosphatase 3 Human genes 0.000 description 1
- 108091022912 Mannose-6-Phosphate Isomerase Proteins 0.000 description 1
- XADCESSVHJOZHK-UHFFFAOYSA-N Meperidine Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCN(C)CC1 XADCESSVHJOZHK-UHFFFAOYSA-N 0.000 description 1
- 101100261636 Methanothermobacter marburgensis (strain ATCC BAA-927 / DSM 2133 / JCM 14651 / NBRC 100331 / OCM 82 / Marburg) trpB2 gene Proteins 0.000 description 1
- 206010061291 Mineral deficiency Diseases 0.000 description 1
- 229910018899 NaMoO3 Inorganic materials 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 229940122060 Ornithine decarboxylase inhibitor Drugs 0.000 description 1
- 101100059332 Oryza sativa subsp. japonica CYCA1-1 gene Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 102100035362 Phosphomannomutase 2 Human genes 0.000 description 1
- 101100124346 Photorhabdus laumondii subsp. laumondii (strain DSM 15139 / CIP 105565 / TT01) hisCD gene Proteins 0.000 description 1
- 108020005089 Plant RNA Proteins 0.000 description 1
- 208000020584 Polyploidy Diseases 0.000 description 1
- 108010068086 Polyubiquitin Proteins 0.000 description 1
- 102100037935 Polyubiquitin-C Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000282941 Rangifer tarandus Species 0.000 description 1
- 108050002653 Retinoblastoma protein Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 235000014548 Rubus moluccanus Nutrition 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 239000012506 Sephacryl® Substances 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 102100038803 Somatotropin Human genes 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 239000012505 Superdex™ Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 101150040313 Wee1 gene Proteins 0.000 description 1
- 101100273808 Xenopus laevis cdk1-b gene Proteins 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- JUGOREOARAHOCO-UHFFFAOYSA-M acetylcholine chloride Chemical compound [Cl-].CC(=O)OCC[N+](C)(C)C JUGOREOARAHOCO-UHFFFAOYSA-M 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000000340 anti-metabolite Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 229940100197 antimetabolite Drugs 0.000 description 1
- 239000002256 antimetabolite Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- PXXJHWLDUBFPOL-UHFFFAOYSA-N benzamidine Chemical compound NC(=N)C1=CC=CC=C1 PXXJHWLDUBFPOL-UHFFFAOYSA-N 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- CXNPLSGKWMLZPZ-UHFFFAOYSA-N blasticidin-S Natural products O1C(C(O)=O)C(NC(=O)CC(N)CCN(C)C(N)=N)C=CC1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-UHFFFAOYSA-N 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000025084 cell cycle arrest Effects 0.000 description 1
- 230000012820 cell cycle checkpoint Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- VLCYCQAOQCDTCN-UHFFFAOYSA-N eflornithine Chemical compound NCCCC(N)(C(F)F)C(O)=O VLCYCQAOQCDTCN-UHFFFAOYSA-N 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 230000000408 embryogenic effect Effects 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 230000034311 endomitotic cell cycle Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 230000006355 external stress Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- 101150054900 gus gene Proteins 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 101150113423 hisD gene Proteins 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000003898 horticulture Methods 0.000 description 1
- PEYVWSJAZONVQK-UHFFFAOYSA-N hydroperoxy(oxo)borane Chemical compound OOB=O PEYVWSJAZONVQK-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 230000020673 lateral root development Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
- 108010052968 leupeptin Proteins 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 230000009826 neoplastic cell growth Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 108010058731 nopaline synthase Proteins 0.000 description 1
- 239000002818 ornithine decarboxylase inhibitor Substances 0.000 description 1
- 230000008723 osmotic stress Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000030040 phloem or xylem histogenesis Effects 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000000865 phosphorylative effect Effects 0.000 description 1
- 238000003976 plant breeding Methods 0.000 description 1
- 239000005648 plant growth regulator Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000001124 posttranscriptional effect Effects 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 108020001580 protein domains Proteins 0.000 description 1
- 230000006916 protein interaction Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000007420 reactivation Effects 0.000 description 1
- 230000034394 regulation of mitosis Effects 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000013278 single fertilization Effects 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000004960 subcellular localization Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 101150081616 trpB gene Proteins 0.000 description 1
- 101150111232 trpB-1 gene Proteins 0.000 description 1
- 238000010396 two-hybrid screening Methods 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000009105 vegetative growth Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Definitions
- the current invention relates to a method for modifying, preferably for enhancing or promoting plant growth and/or yield in plants and for modifying their architecture and to the transgenic plants obtainable by this method.
- the invention concerns the simultaneous ectopic expression and/or overexpression of at least two cell cycle interacting proteins capable of forming a complex and specifically a CDK and an interacting cyclin; said co- overexpression results in an unexpected growth and architectural characteristics such as enhanced root and/or shoot growth in plants.
- the eukaryotic cell division cycle can be divided in four main phases: the G1 phase or first gap phase, the S phase during which the DNA is duplicated, the G2 phase or second gap phase, and the M phase during which karyo- and cytokinesis take place.
- the major checkpoints regulating the progression through the cell cycle are situated at the G1/S and G2/M transitions. If the conditions are inadequate for the cell to continue its cycle, a block can occur at one or both transition points.
- the cell cycle can also be blocked at other transition points which had not until recently been considered important, namely M/G1.
- CDKs cyclin dependent kinases
- CDK proteins in diverse plant species, among which at least five types can be distinguished on the basis of their sequences (for a compilation see Segers et al., 1997).
- Arabidopsis thaliana two CDKs, each belonging to a different family, have been characterised.
- One such example is the CDC2ak ⁇ gene, which contains the conserved PSTAIRE amino acid motif, and is constitutively expressed during the cell cycle at transcriptional and protein level.
- the associated kinase activity is maximal at the G1/S and G2/M transitions, suggesting a role at both checkpoints (Hemerly et al, 1993; Burssens et al., 1998; Segers et al; 1996).
- CDC2bAt contains a PPTALRE motif and its mRNA levels are preferentially present during S and G2 phase (Segers et al, 1996 and references cited therein). The protein follows the transcriptional level but the CDC2b kinase activity becomes only maximal during mitosis, implying a role during the M phase. Cyciins
- Cyciins share a highly homologous region of about 100 amino acids termed the "cyclin box" which is required for their interaction with the CDK catalytic subunit.
- the plant A- and B- type cyciins are the so called 'mitotic cyciins' with an important function during mitosis, while the D-type cyciins (so called G1 cyciins) are thought to play a key role at the entry of S phase.
- the transcriptional regulation of the mitotic cyciins CYCA2;1 and CYCB1;1 of A. thaliana has been analysed in detail in synchronised tobacco BY2-cells. Promoter activity of CYCA2; 1 is switched on upon entry of S phase and persists during G2 phase to be maximal at the end of G2 phase.
- CYCB1;1 is expressed in a more narrow window of the cell cycle, namely upon exit of S phase and G2 phase with maximal mRNA levels at the entry of mitosis (Shaul et al 1996). Moreover, by developmental expression analysis, the presence of CYCB1;1 transcripts was exclusively linked with actively dividing cells (Ferreira et al, 1994), implying that CYCB1;1 is involved in the regulation of mitosis. Plant D cyciins, by analogy with their animal homologues, have been proposed to control the G1 progression in response to growth factors and nutrients (Dahl et al., 1995; Soni et al., 1995).
- CDKs and cyciins interact to form functional protein complexes.
- B ⁇ gre et al. (1997) have found that protein fractions from alfalfa extracts corresponding to monomeric CDKs are essentially devoid of kinase activity as measured by histone H1 phosphorylation and, on the other hand, alfalfa protein complexes immunoprecipitated with antibodies against the human cyclin A or alfalfa cyclin CYCB2;2 exhibit appropriate histone H1 kinase activity (Magyar et al., 1993; 1997).
- a number of other cell cycle proteins have been shown to interact with one another to form active complexes. Some complexes relevant to the invention are involved in the initiation of DNA replication and ceil division including facilitating the entry into S phase of quielich cells (see Leatherwood 1998, Helin 1998 for reviews).
- the complexes include ORC1/CDC6 or CDC7/DBF4 or E2F/DP. Importance of the cell cycle
- CDK activity depends on the interaction with regulatory cyciins and is limiting for cell cycle progression. Different CDK/cyclin complexes act at different time-points of the cell cycle, although different CDK/cyclin complexes may also act at the same time-points of the cell cycle.
- Complexes of A-type CDKs (such as CDC2a) with D-type cyciins are acting at the G1 phase and are involved in recruiting GO cells in the G1 phase of the cell cycle.
- Complexes between A-type CDKs and A-type cyciins are operational in S- and G2 phase.
- G2- and M-phase complexes between A-and B-type CDKs and B-type cyciins are controlling the progression of the cell cycle.
- Two major checkpoints are operational during the cell cycle, one at the G1/S boundary and one at the G2/M boundary. At these checkpoints the activity of the appropriate CDK/cyclin complexes is controlled, either by interaction with inhibitory proteins (at the G1/S transition), or by inhibitory phosphorylations mediated by a Wee1 kinase (at the G2/M transition). Only when the conditions are favourable is the CDK/cyclin kinase activity restored either by inactivation of the inhibitor, or by dephosphorylation of the CDK/cyclin complex through the action of CDC25.
- the current invention describes methods to overcome the inhibition of CDK/cyclin activity.
- different effects are expected in plant growth, yield or architecture.
- the technical problem underlying the present invention is to provide means and methods for enhancement of plant growth, and/or yield and/or modified architecture in particular in the entire plant, or specific parts of said plant, which are particularly useful in agriculture.
- the present invention relates to a method for modifying plant growth and/or yield and/or architecture, in particular modifications to plant growth and development mediated by cell cycle protein complexes, thereby improving the agricultural and commercial value of these plants.
- a method for modifying plant growth and/or yield and/or architecture in particular modifications to plant growth and development mediated by cell cycle protein complexes, thereby improving the agricultural and commercial value of these plants.
- the overexpression of at least two proteins forming subunits of a protein complex in particular cells, tissues or organs of the plant would produce enhanced plant growth and/or yield and/or architecture compared to otherwise non-transformed plants.
- the present invention relates to a method for modifying plant growth and/or yield and/or modifying architecture comprising introducing into a plant cell, plant tissue or plant (a) nucleic acid molecule(s) or regulatory sequence(s), wherein the introduction of the nucleic acid molecule(s) or regulatory sequence(s) result(s) in an increased or de novo expression of at least two cell cycle interacting proteins capable of forming a (heteromeric) complex in a plant cell.
- the simultaneous ectopic expression and/or overexpression of more than one cell cycle interacting protein of which, preferably, at least one is a protein kinase and at least one is a protein forming a complex with such protein kinase and regulating the activity of said protein kinase, leads to enhanced plant growth and/or yield and/or modified architecture compared to wild type plants.
- the -current invention demonstrates that it will be advantageous to use co-expression of both CYCB1 ;1 and CDC2a since this leads to growth stimulation under conditions in which CYCB1 ;1 alone does not stimulate growth.
- the combined overexpression may therefore stimulate growth under a wider range of conditions, including environmental conditions, such as high or low availability of water and nutrients, high or low temperature, high or low light, etc.
- the protein kinase is a cyclin dependent kinase (CDK).
- CDK is a PSTAIRE type cyclin dependent kinase.
- CDK is a CDC2a.
- the CDK is a B- type cyclin dependent kinase namely CDC2b.
- the second protein is a cyclin.
- the cyclin is a G1 cyclin such as a D- type cyclin (e.g. CYCD4;1) or an E-type cyclin.
- the cyclin is a mitotic cyclin such as a B-type cyclin like CYCB1 ;1.
- cell cycle interacting proteins to be coexpressed and forming the relevant cell cycle complex are ORC1 with CDC6 or CDC7 with DBF4 or E2F with DP.
- both proteins of the cell cycle complex are ectopically expressed under the control of a constitutive promoter such as the 35S promoter.
- a constitutive promoter such as the 35S promoter.
- both proteins may also be expressed under the control of other promoters such as tissue specific promoters, which may be the same for both proteins or which may be different as long as those promoters are driving simultaneous expression of both proteins in at least one tissue. Growth stimulation occurs in particular in those tissues in which both proteins are simultaneously (over)expressed.
- tissue specific promoters which may be the same for both proteins or which may be different as long as those promoters are driving simultaneous expression of both proteins in at least one tissue. Growth stimulation occurs in particular in those tissues in which both proteins are simultaneously (over)expressed.
- the man skilled in the art will see various ways of implementing said method in plants.
- plants are transformed separately with one protein of the cell cycle complex, e.g. or protein kinase such as CDC2a, and with the other interacting cell cycle protein of the complex such as a regulatory protein of such protein or protein kinase, e.g. CYCD4;1.
- one protein of the cell cycle complex e.g. or protein kinase such as CDC2a
- the other interacting cell cycle protein of the complex such as a regulatory protein of such protein or protein kinase, e.g. CYCD4;1.
- Such plants are subsequently crossed and the offspring plants that contain both transgenes are selected and demonstrated to exhibit modified growth, yield and/or architectural characteristics in comparison with a wild type plant.
- plants exhibiting simultaneous ectopic expression and/or overexpression of the two genes according to the present invention will be obtained via so called cotransformation.
- Each gene will be present in a different vector or gene construct (e.g. an Agrobacterium vector) and during the transformation step both vectors will be used in combination.
- the success rate of cotransformation will be highest when both vectors contain a different marker gene (e.g. bar, nptll, hyg,..) and when the selection will be performed with both selective agents; it is also possible to use only one selectable marker gene and its corresponding selective agent and then to identify cotransformants by means of genetic analysis (e.g. PCR based methods).
- each gene will be present on the same vector or gene construct and the plant transformed with such a vector.
- vectors will be constructed in accordance with the invention.
- Such vectors will contain a nucleic acid molecule, e.g. a gene, encoding one protein of the cell cycle complex, e.g. encoding a protein kinase, under the control of a given promoter sequence as well as a nucleic acid molecule, e.g. a gene, encoding the other interacting cell cycle protein of the said complex, e.g. regulating the protein kinase activity, under the control of a given promoter sequence.
- a nucleic acid molecule e.g. a gene
- encoding the other interacting cell cycle protein of the said complex e.g. regulating the protein kinase activity
- control sequences may be present.
- the promoters of both genes may be identical or may be different as long as there is simultaneous expression in at least one tissue. Bidirectional promoters such as the TR promoter may also be used to drive expression of both genes.
- transgenic plants, plant tissues, plant organs or plant cells obtained by the method according to the invention are obtainable from a monocotyiedonous plant or dicotyledonous plant.
- the invention also relates to a transgenic plant cell comprising an overexpressed protein complex obtainable according to any of the methods of the present invention.
- a transgenic plant or plant tissue comprising said plant cells and harvestable parts or propagation material of those plants are part of the invention too.
- the invention also relates to the vectors necessary to obtain transformed plants in accordance with the previous embodiments of the invention, those vectors are characterized by the fact that they contain both a protein kinase gene and a gene encoding a regulatory protein regulating the activity of said protein kinase.
- the invention is also related to utilisation in hybrid seeds in the following way.
- Two transgenes of interest each present in a homozygous condition in one of the parents of a hybrid, will be present in combination and in a heterozygous condition in the hybrid seed, thus providing the hybrid seed with the benefit of accelerated growth based on the simultaneous ectopic expression and/or overexpression of the two transgenes.
- Seed harvested from the F1 hybrid plants will segregate for both transgenes and only 9 out of 16 plants of the F2 generation will possess the two transgenes, thus resulting in additional protection of the value of the hybrid seed.
- the present invention relates to composition comprising the above-described nucleic acid molecules, regulatory sequences or vectors, containing the same identified by the method of the present invention.
- the invention relates to the use of the transformed cells or the above described nucleic acid molecules, regulatory sequences or vectors for the production of more biomass, secondary metabolites or additives for plant culturing in plant cell culture.
- the present invention relates to a method for modifying plant growth and/or yield and/or modifying architecture comprising introducing into a plant cell, plant tissue or plant (a) nucleic acid molecule(s) or regulatory sequence(s), wherein the introduction of the nucleic acid molecule(s) or regulatory sequence(s) result(s) in an increased or de novo expression of at least two cell cycle interacting proteins capable of forming a (heteromeric) complex in a plant cell.
- growth is a concept well known to the person skilled in the art and includes increased crop growth and/or enhanced biomass.
- modifying plant growth and/or yield refers to a general alteration in the growth of the plant, its tissues or organs or the yield as examplified below.
- modifying plant growth relates to an acceleration, enhancement or promotion of plant growth.
- “Architecture” refers to the general morphology of a plant including any one of more structural features including the shape, size, number, colour, texture, arrangement and pattemation of any cell, tissue or organ or groups of cells, tissues, or organs of plants including the root, leaf, shoot, fruit, petiole, trichome, flower, sepals, petal, hypocotyl, stigma, style, stamen, pollen, ovule, seed, embryo, endosperm, seed coat, aleurone, fibre nodule, cambium, wood, heartwood, parenchyma, erenchyma, selve element, phloem, or vascular tissue amongst others.
- Modifying yield refers to an altered, preferably increased or enhanced biomass of either the total plant or specific tissues or organs of plants such as root, leaf, shoot, fruit, petiole, trichome, flower, sepals, petal, hypocotyl, stigma, style, stamen, pollen, ovule, seed, bulb, embryo, endosperm, seed coat, aleurone, fibre, nodule, cambium, wood, heartwood, parenchyma, erenchyma, seive element, phloem, or vascular tissue.
- Yield also refers to accumulation of metabolites and/or the sink/source relationships in the total plant or specific cells, tissues or organs of the plant such as root, leaf, shoot, fruit, petiole, trichome, flower, sepals, petal, hypocotyl, stigma, style, stamen, pollen, ovule, seed, embryo, endosperm, seed coat, aleurone, fibre, nodule, cambium, wood, heartwood, parenchyma, erenchyma, seive element, phloem, or vascular tissue. This means, for instance that increased growth and/or yield results from increased growth rate or increased root size or shoot growth or, alternatively, in an increased yield because of enhanced fruit growth.
- plants may modify one or more plant growth and/or architectural and/or yield characteristics in response to external stimuli, such as, for example, a plant pathogenic infection, or an external stress or environmental stress (e.g. anoxia, hypoxia, high temperature, low temperatures, light, daylength, drought, flooding, salt stress, dehydration, heavy metal contamination, nutrient/mineral deficiency, amongst others).
- external stimuli such as, for example, a plant pathogenic infection, or an external stress or environmental stress (e.g. anoxia, hypoxia, high temperature, low temperatures, light, daylength, drought, flooding, salt stress, dehydration, heavy metal contamination, nutrient/mineral deficiency, amongst others).
- anoxia e.g. anoxia, hypoxia, high temperature, low temperatures, light, daylength, drought, flooding, salt stress, dehydration, heavy metal contamination, nutrient/mineral deficiency, amongst others.
- cell cycle shall be taken to include the cyclic biochemical and structural events associated with growth and with division of cells, and in particular with the regulation of the replication of DNA and mitosis.
- Cell cycle includes phases called: GO (gap 0), G1 (gap 1), DNA replication (S), G2 (gap 2), and mitosis including cytokinesis (M). Normally these four phases occur sequentially.
- the cell cycle also includes modified cycles such as endomitosis, acytokinesis, polyploidy, polyteny, endopolyploidisation and endoreduplication or endoreplication.
- cell cycle interacting protein means a protein which exerts control on or regulates or is required for the cell cycle or part thereof, of a cell, tissue, organ or whole organism and/or DNA replication. It may also be capable of binding to, regulating or being regulated by cyclin dependent kinases or their subunits.
- the term also includes peptides, polypeptides, fragments, variants, homologues, alleles or precursors (e.g. preproproteins or preproteins) thereof.
- the cell cycle interacting protein is preferably of plant origin, although it may also be the yeast homologues thereof.
- the cell cycle interacting protein is preferably a protein kinase, in particular a cyclin dependent kinase (CDK) for example an A-type (CDC2a) or a B-type (CDC2b) CDK.
- CDK cyclin dependent kinase
- the cell cycle interacting protein is also preferably a cyclin, including cyciins A, B, C, D and E, and in particular CYCA1 ; 1 , CYCA2;1 , CYCA3;1 , CYCB 1 ;1 , CYCB1 ;2, CYCB2;2, CYCD1 ;1 , CYCD2;1.
- CYCD3; 1 , and CYCD4;1 Evans et al. 1983; Francis et al. 1998; Labbe et al. 1989; Murray and Kirschner 1989; Renaudin et al 1996; Soni et al 1995; Sorrell et al 1999; Swenson et al 1986). Cyciins are also referred to in Table 1.
- the cell cycle interacting protein preferably includes proteins involved in the control of entry and progression through S phase in particular ORC1 , CDC6, (Nevins, 1992; Liang, 1995) CDC7, DBF4 kinase, E2F (WO 99/58681 ; WO 99/53075) and DP (WO 99/53075).
- the complex formation in the cell leads to the induction of potential processes of cell division, preferably cell proliferation.
- cell cycle interacting proteins include, but are not limited to protein kinases e.g., cyclin-dependent kinases (CDKs), and their activating associated subunits, namely cyciins (CYCs).
- CDKs protein kinases
- CYCs cyciins
- Other cell cycle interacting proteins capable of forming a (heteromeric) complex include ORC1 and CDC6, CDC7 and DBF4, and E2F and DP.
- cell cycle complex The resulting complex of at least two cell cycle interacting proteins capable of forming a (heteromeric) complex is termed a "cell cycle complex".
- a preferred cell cycle complex is a CDK/cyclin complex, namely the complex formed when a preferably functional cyclin associates with its appropriate CDK, preferably a functional form thereof.
- Such complexes may be active in phosphorylating proteins and may or may not contain additional protein species.
- preferred ceil cycle complexes are ORC1/CDC6 or CDC7/DBF4 or E2F/DP.
- the invention includes modified forms of a cell cycle interacting protein, including homologues or analogues (as defined below) thereof.
- a preferred modified cell cycle interacting protein is a modified CDK protein wherein the modification removes the inhibitory effect of phosphates on CDC2, in particular the threonine-14 and/or tyrosine-15 have been substituted with non- phosphorylatable residues such as phenylalanine and/or alanine.
- modified CDKs include Cdc2aA14F15 and Cdc2bA14F15.
- Another form of modification includes the mutation of the amino acid residue responsible for ATP binding, namely the D residue is replaced with an N residue to form for example Cdc2b.N161 , Cdc2f.N164, or Cdc2aN147.
- modified cell cycle interacting protein is a modified cyclin protein wherein the modification results in the stablisation of the cyclin.
- modification may be the result of the mutation or complete or partial removal of the destruction box (D box) motif (RxxLxx[L/l]xN) in the cyclin N-terminal domain (where R and L residues are highly conserved and x stands for any amino acid) (Plesse et al 1998).
- modified cyciins for use in the present invention include CYCA2;2 ⁇ 64, CYCA2;3 ⁇ 63, CYCB2;1 ⁇ 44 (where ⁇ - is the truncated form lacking the N-terminal part containing the destruction box).
- “Homologues” of cell cycie interacting proteins are those peptides, oiigope ' ptides, polypeptides, proteins and enzymes which contain amino acid substitutions, deletions and/or additions relative to a non-mutant or wild-type cell cycle interacting protein polypeptide, without altering one or more of its cell cycle control properties.
- amino acids present in the protein can be replaced by other amino acids having similar properties, for example hydrophobicity, hydrophilicity, hydrophobic moment, antigenicity, propensity to form or break helical structures or sheet structures, and so on.
- Substitutional variants are those in which at least one residue in the cell cycle interacting protein amino acid sequence has been removed and a different residue inserted in its place.
- Amino acid substitutions are typically of single residues, but may be clustered depending upon functional constraints placed upon the polypeptide; insertions will usually be of the order of about 1-10 amino acid residues and deletions will range from about 1-20 residues.
- amino acid substitutions will comprise conservative amino acid substitutions, such as those described supra.
- Insertional amino acid sequence variants are those in which one or more amino acid residues are introduced into a predetermined site in the cell cycle interacting protein. Insertions can comprise amino- terminal and/or carboxyl terminal fusions as well as intra-sequence insertions of single or multiple amino acids. Generally, insertions within the amino acid sequence will be smaller than amino or carboxyl terminal fusions, of the order of about 1 to 4 residues.
- Deletional variants are characterised by the removal of one or more amino acids from the cell cycle interacting protein sequence.
- Amino acid variants of the cell cycle interacting polypeptide may readily be made using peptide synthetic techniques well known in the art, such as solid phase peptide synthesis and the like, or by recombinant DNA manipulations.
- the manipulation of DNA sequences to produce variant proteins which manifest as substitutional, insertional or deletional variants are well known in the art.
- techniques for making substitution mutations at predetermined sites in DNA having known sequence are well known to those skilled in the art, such as by M13 mutagenesis or other site-directed mutagenesis protocol.
- Analogues of a cell cycle interacting protein are defined as those peptides, oligopeptides, polypeptides, proteins and enzymes which are functionally equivalent to a cell cycle interacting protein.
- Analogues of a cell cycle interacting protein include those CDKs, cyciins etc and modified versions thereof that comprise peptides, polypeptides, proteins, and enzymes that are capable of functioning in a plant cell and/or plant tissue and/or plant organ and/or whole plant to produce the same modified plant growth and/or yield and/or architectural characteristics as the ectopic expression and/or (over)expression of such cell cycle interacting proteins forming a cell cycle complex.
- nucleic acid molecule(s) refers to a polymeric form of nucleotides of any length, either ribonucleotides or deoxyribonucleotides. This term refers only to the primary structure of the molecule. Thus, this term includes double- and single-stranded DNA, and RNA. It also includes known types of modifications, for example, methylation, "caps" substitution of one or more of the naturally occurring nucleotides with an analog.
- the present invention denotes nucleic acid molecules which enhances expression of said cell cycle interacting proteins.
- said nucleic acid molecules comprise a coding sequence of a mentioned protein or of a regulatory protein, e.g., a transcription factor, capable of inducing the expression of said cell cycle interacting protein.
- regulatory sequence denotes a nucleic acid molecule increasing the expression of the said protein(s), e.g. of cell cycle interacting protein(s), due to its integration into the genome of a plant cell in close proximity to the gene(s), e.g. encoding said cell cycle interacting protein(s).
- Such regulatory sequences comprise promoters, enhancers, inactivated silencer intron sequences, 3'UTR and/or 5'UTR coding regions, protein and/or RNA stabilizing elements or other gene expression control elements which are known to activate gene expression and/or increase the amount of the gene products.
- nucleic acid molecule(s) leads to de novo expression, or if the mentioned regulatory sequence(s) is used to increase in expression of said proteins, resulting in an increased amount of active protein in the cell.
- the present invention is aiming at providing de novo and/or increased activity of e.g., cell cycle interacting proteins.
- transgenic lines overexpressing both CDC2a and CYCB1 ;1 were obtained by crossing a line homozygous for a 35ScaMV-CDC2a construct with a line homozygous for a modified 35S- CYCB1 ;1 construct, it is clear for a person skilled in the art that the same effect could also be obtained by introducing in one plant e.g., a DNA construct in which both the CDC2a and CYCB1 ;1 are placed under a constitutive or tissue specific promoter.
- nucleic acid molecule(s) encode(s) said cell cycle interacting protein(s) and the regulatory sequence(s) is (are) capable of increasing the expression of a gene encoding said cell cycle interacting protein(s).
- a nucleic acid molecule comprises a coding sequence for a cell cycle interacting protein as defined herein.
- a “coding sequence” is a nucleotide sequence which is transcribed into mRNA and/or translated into a polypeptide when placed under the control of appropriate regulatory sequences. The boundaries of the coding sequence are determined by a translation start codon at the 5'-terminus and a translation stop codon at the 3'-terminus.
- a coding sequence can include, but is not limited to mRNA, cDNA, recombinant nucleotide sequences or genomic DNA, while introns may be present as well under certain circumstances.
- one of said cell cyclin interacting proteins is a protein kinase. Therefore, in a preferred embodiment of the method of the present invention one of said cell cycle interacting proteins is a protein kinase.
- said protein kinase is a cyclin-dependent kinase (CDK) and the other of said cell cycle interacting proteins is a cyclin.
- CDKs and cyciins that can be employed according to the invention are described in Table 1 , in Segers et al., 1997 or Renaudin et al., 1996, (the disclosure contents of which are hereby incorporated by reference). Preferred coexpression of combinations of CDKs and cyciins in a cell cycle complex and the resulting phenotype are described below:
- A-type CDK with a cyclin D2 or cyclin D4 Without being bound by any theory or mode of action overexpression of A-type CDKs and cyclin D2 and/or cyclin D4 shortens the G1 phase and overrides the checkpoints, which monitors the availability of sugars. As such plants complete their lifecycle (from seed to seed) faster. It also is expected that plants can complete extra rounds of cell division resulting in an enhanced production of biomass.
- meristem specific promoters e.g. promoters active in root- or shoot meristems, or subdomains thereof, promoters active during early seed development, cambium specific promoters etc. growth of particular organs can be enhanced.
- A-type CDK with a cyclin D4 Without being bound by any theory or mode of action overexpression of A-type CDKs and cyclin D4 elevates the threshold that cells needs to re-enter the cell cycle. As such plants cells are more easily regenerated and form more structures (such as lateral roots) of which the formation is dependent on the re-activation of the cell cycle (GO' to G1 transition). 3.
- A-type CDK with a D-type cyclin The G1/S checkpoint as well as the G2/M checkpoint is of importance for the arrest of cell division under environmental stress conditions. It is anticipated that overexpression of A-type CDKs and D- type cyciins would result in plants with growth characteristics that are more tolerant to stress conditions which cause a cell cycle arrest at the G1/S boundary.
- A-type CDK with a B-type cyclin or a B-type CDK with a B-type cyclin overexpression of A-type and/or B-type CDKs with B-type cyciins overrides the G2/M checkpoints.
- Such plants are expected to have growth characteristics less sensitive to environmental stress conditions, such as osmotic stress and complete faster the G2 phase. Furthermore, cells will become less dependent upon the continuous availability of cytokinins.
- A-type CDK with a D-type cyclin Without being bound by any theory or mode of action the G1 phase is thought to be of importance for growth control of plant cells and an arrest of cells at the G1 phase (e.g. through the use of a dominant negative A-type CDK) cause cells to become larger.
- A-type CDKs and D-type cyciins enhances the progression through the G1 phase and reduces the average cell size.
- More cells per unit surface results in a modification of the tissue texture (relative more cell wall material, more membranes etc.) and has an important impact on quality traits. For example the difference between spring and summer wood in trees is largely a consequence of differences in cell size.
- fibrelength of cells e.g. cotton fibres
- B-type CDK with an A-type' cyclin plant A-type cyciins are expressed from mid S till early M phase, therefore it can be expected that the co-expression of CDC2bAt with CYCA results in an enhanced progression though these cell cycle phases. Also cells may become less sensitive to the G2/M checkpoint control, making the plants putatively less sensitive to stress conditions and plant growth regulators which operate at this transition point. The result would be that these plants grow better in suboptimal conditions, compared to normal plants, noting that suboptimal conditions may occur frequently even under good agronomical conditions. A higher yield is anticipated under most, but particularly under suboptimal/marginal, agricultural conditions.
- Table 2 also illustrates preferred CDK/cyclin cell cycle complexes for use in the performance of the application:
- nucleic acid molecule(s) encode(s) at least a catalytic and/or regulatory subunit of said cell cycle interacting protein(s).
- Components of CDK/cyclin complexes that can be employed in accordance with the method of the present invention and how to obtain them are known to the person in skilled and are described, e.g., in WO 98/41642, WO 92/09685 the disclosure of which is hereby incorporated by reference.
- One aspect of the invention provides a method of modifying plant growth and/or yield and/or architecture by expressing in particular cells, tissues or organs of a plant, at least two subunits of a cell cycle complex operably under the control of a regulatable promoter sequence selected from the list comprising cell-specific promoter sequences, tissues-specific promoter sequences and organ-specific promoter sequences.
- a regulatable promoter sequence selected from the list comprising cell-specific promoter sequences, tissues-specific promoter sequences and organ-specific promoter sequences. Examples of such promoters include promoters which are:
- stem-expressible and more specifically in the stem cambium to increase strength and thickness of a plant stem to confer improved stability and wind-resistance on the plant
- tuber expressible to increase or improve tuber production in the plant
- seed expressible to increase seed production in plants in particular to increase seed set and/or seed production and/or seed yield.
- endosperm expressible those skilled in the art will be aware that grain yield in crop plants is largely a function of the amount of starch produced in the endosperm of the seed. The amount of protein produced in the endosperm is also a contributing factor to grain yield. In contrast that embryo and aleurone layers contribute little in terms of the total weight of the mature grain. Therefore endosperm-expressible promoters provide the advantage of increasing grain size and grain yield of the plant.
- root expressible to increase or enhance the production of roots or storage organs derived from roots
- nodule expressible to increase the nitrogen-fixing capability of a plant.
- embryo expressible embryo size being important for growth after germination
- promoters suitable for use in gene constructs of the present invention include those listed in Table 3, amongst others.
- the promoters listed in Table 3 are provided for the purposes of exemplification only and the present invention is not to be limited by the list provided therein. Those skilled in the art will readily be in a position to provide additional promoters that are useful in performing the present invention.
- Table 4 describes constitutive promoters for use in the present invention.
- Preferred promoters may contain additional copies of one or more specific regulatory elements, to further enhance expression and/or to alter the spatial expression and/or temporal expression of a nucleic acid molecule to which it is operably connected.
- copper-responsive, glucocorticoid- responsive or dexamethasone-responsive regulatory elements may be placed adjacent to a heteroiogous promoter sequence driving expression of a nucleic acid molecule to confer copper inducible, giucocorticoid-inducible, or dexamethasone-inducible expression respectively, on said nucleic acid molecule.
- nucleic acid molecule(s) is (are) operatively linked to control sequences allowing the expression of the nucleic acid molecule(s) in the plant.
- control sequences comprise a promoter, enhancer, silencer, intron sequences, 3'UTR and/or 5'UTR regions, protein and/or RNA stabilizing elements.
- said control sequence is a chimeric, tissue specific, constitutive or inducible promoter.
- both proteins are expressed under the control of a promoter which is active in non differentiated plant cells or in plant protoplasts growing in an artificial medium.
- the increased growth rate of the cells results in increasing growth of the plant cells in plant cell culture, thus allowing the production of more biomass in plant cell culture.
- Plant cell production in plant culture can be useful for the production of certain secondary metabolites of plants which may be useful in the pharmaceutical, cosmetics,* food industry etc.
- the present invention further relates to a nucleic acid molecule encoding at least two cell cycle interacting proteins as mentioned above.
- the present invention also relates to vectors, particularly plasmids, cosmids, viruses, bacteriophages and other vectors used conventionally in genetic engineering that comprise the nucleic acid molecule or at least two nucleic acid molecules and/or regulatory sequences according to the invention.
- vectors particularly plasmids, cosmids, viruses, bacteriophages and other vectors used conventionally in genetic engineering that comprise the nucleic acid molecule or at least two nucleic acid molecules and/or regulatory sequences according to the invention.
- Methods which are well known to those skilled in the art can be used to construct various plasmids and vectors; see, for example, the techniques described in Sambrook, Molecular Cloning A Laboratory Manual, Cold Spring Harbor Laboratory (1989) N.Y. and Ausubel, Current Protocols in Molecular Biology, Green Publishing Associates and Wiley Interscience, N.Y. (1989), (1994).
- Plasmids and vectors to be preferably employed in accordance with the present invention include those well known in the art.
- nucleic acid molecules and vectors of the invention can be reconstituted into " liposomes for delivery to target cells.
- the vector of the present invention comprises separate nucleic acid molecules encoding at least one of said cell cycle interacting proteins.
- nucleic acid molecule present in the vector is linked to (a) control sequence(s) which allow the expression of the nucleic acid molecule or of cell cycle interacting proteins in a host cell, e.g. prokaryotic and/or eukaryotic cells.
- control sequence refers to regulatory DNA sequences which are necessary to effect the expression of coding sequences to which they are ligated. The nature of such control sequences differs depending upon the host organism. In prokaryotes, control sequences generally include promoter, ribosomal binding site, and terminators. In eukaryotes generally control sequences include promoters, terminators and, in some instances, enhancers, transactivators or transcription factors. The term “control sequence” is intended to include, at a minimum, all components the presence of which are necessary for expression, and may also include additional advantageous components. Preferably, said control sequence comprises a constitutive, chimeric, tissue specific or inducible promoter.
- operably linked refers to a juxtaposition wherein the components so described are in a relationship permitting them to function in their intended manner.
- a control sequence "operably linked" to a coding sequence is ligated in such a way that expression of the coding sequence is achieved under conditions compatible with the control sequences.
- the control sequence is a promoter, it is obvious for a skilled person that double-stranded nucleic acid is used.
- the vector of the invention is preferably an expression vector.
- An "expression vector” is a construct that can be used to transform a selected host cell and provides for expression of a coding sequence in the selected host.
- Expression vectors can for instance be cloning vectors, binary vectors or integrating vectors.
- Expression comprises transcription of the nucleic acid molecule preferably into a translatable mRNA.
- Regulatory elements ensuring expression in prokaryotic and/or eukaryotic cells are well known to those skilled in the art.
- eukaryotic cells they comprise normally promoters ensuring initiation of transcription and optionally poly-A signals ensuring termination of transcription and stabilization of the transcript, for example, those of the 35S RNA from Cauliflower Mosaic Virus (CaMV).
- CaMV Cauliflower Mosaic Virus
- TMV tobaccos mosaic virus
- Additional regulatory elements may include transcriptional as well as translational enhancers.
- the above- described vectors of the invention comprises a selectable and/or scorable marker.
- Selectable marker genes useful for the selection of transformed plant cells, callus, plant tissue and plants are well known to those skilled in the art and comprise, for example, antimetabolite resistance as the basis of selection for dhfr, which confers resistance to methotrexate (Reiss, Plant Physiol. (Life Sci. Adv.) 13 (1994), 143-149); npt, which confers resistance to the aminoglycosides neomycin, kanamycin and paromycin (Herrera-Estrella, EMBO J. 2 (1983), 987-995) and hygro, which confers resistance to hygromycin (Marsh, Gene 32 (1984), 481-485).
- trpB which allows cells to utilize indole in place of tryptophan
- hisD which allows cells to utilize histinol in place of histidine
- mannose-6- phosphate isomerase which allows cells to utilize mannose
- ODC ornithine decarboxylase
- DFMO ornithine decarboxylase
- deaminase from Aspergillus terreus which confers resistance to Blasticidin S (Tamura, Biosci. Biotechnol. Biochem. 59 (1995), 2336-2338).
- Useful scorable marker are also known to those skilled in the art and are commercially available.
- said marker is a gene encoding luciferase (Giacomin, PI. Sci. 116 (1996), 59-72; Scikantha, J. Bact. 178 (1996), 121 ), green fluorescent protein (Gerdes, FEBS Lett. 389 (1996), 44- 47) or ⁇ -glucuronidase (Jefferson, EMBO J. 6 (1987), 3901-3907).
- luciferase PI. Sci. 116 (1996), 59-72; Scikantha, J. Bact. 178 (1996), 121
- green fluorescent protein Gerdes, FEBS Lett. 389 (1996), 44- 47
- ⁇ -glucuronidase Jefferson, EMBO J. 6 (1987), 3901-3907.
- the vectors used according to a method of the present invention can carry nucleic acid molecules encoding the above-mentioned enzymes or enzymatical fragments thereof and fusions of targeting signals to these molecules.
- said nucleic acid molecules may be under the control of the same regulatory elements or may be separately controlled for expression.
- the nucleic acid molecules encoding e.g. the domains of cell cycle interacting protein(s) can be expressed in the form of a single mRNA as transcriptional and optionally translational fusions.
- domains are produced as separate polypeptides or in the latter option as a fusion polypeptide that is further processed into the individual proteins, for example via a cleavage site for proteinases that has been incorporated between the amino acid sequences of both proteins.
- the resultant protein domains can then self- assemble in vivo.
- the domains may also be expressed as a bi- or multifunctional polypeptide, preferably disposed by a peptide linker which advantageously allows for sufficient flexibility of both proteins.
- said peptide linker comprises plural, hydrophilic, peptide-bonded amino acids of a length sufficient to span the distance between the C-terminal end of one of said proteins and the N-terminal end of the other of said proteins when said polypeptide assumes a conformation suitable for biological activity of both proteins when disposed in aqueous solution in the plant cell.
- dicistronic mRNA Reinitiation
- Brinck-Peterson 1996
- Hotze (1995) bifunctional proteins are discussed in Lamp (1998) and Dumas (1997) and for linker peptide and protease refer to Doskeland (1996).
- the present invention furthermore relates to host cells comprising a vector as described above or the mentioned complex overexpressed in a plant cell according to the invention wherein the nucleic acid molecule is foreign to the host cell.
- nucleic acid molecule is either heteroiogous with respect to the host cell, this means derived from a cell or organism with a different genomic background, or is homologous with respect to the host cell but located in a different genomic environment than the naturally occurring counterpart of said nucleic acid molecule. This means that, if the nucleic acid molecule is homologous with respect to the host cell, it is not located in its natural location in the genome of said host cell, in particular it is surrounded by different genes. In this case the nucleic acid molecule may be either under the control of its own promoter or under the control of a heteroiogous promoter.
- the vector or nucleic acid molecule according to the invention which is present in the host cell may either be integrated into the genome of the host cell or it may be maintained in some form extrachromosomally.
- the host cell can be any prokaryotic or eukaryotic cell, such as bacterial, insect, fungal, plant or animai cells.
- Preferred fungal cells are, for example, those of the genus Saccharomyces, in particular those of the species S. cerevisiae.
- a composition comprising vectors wherein each vector contains at least one nucleic acid molecule encoding at least one cell cycle interacting protein is disclosed. The expression of said vectors results in the production of at least two cell cycle interacting proteins and assembly of the same in a complex in vitro or in vivo.
- Another object of the invention is a method for the preparation of a cell cycle complex which comprises the cultivation of host cells according to the invention which, due to the presence of a vector or a nucleic acid molecule according to the invention, are able to express such a cell cycle complex, under conditions which allow expression of the cell cycle complex and recovering of the so-produced complex from the culture.
- the present invention relates to a cell cycle complex obtainable by said method of the present invention or encodable by the nucleic acid molecule of the present invention.
- polypeptide refers to a polymer of amino acids (amino acid sequence) and does not refer to a specific length of the molecule. Thus peptides and oligopeptides are included within the definition of polypeptide.
- polypeptides for example, glycosylations, acetylations, phosphorylations and the like. Included within the definition are, for example, polypeptides containing one or more analogs of an amino acid (including, for example, unnatural amino acids, etc.), polypeptides with substituted linkages, as well as other modifications known in the art, both naturally occurring and non-naturally occurring.
- Methods for the introduction of foreign DNA into plants are also well known in the art. These include, for example, the transformation of plant cells or tissues with T-DNA using Agrobacterium tumefaciens or Agrobacterium rhizogenes, the fusion of protoplasts, direct gene transfer (see, e.g., EP-A 164 575), injection, electroporation, biolistic methods like particle bombardment, pollen- mediated transformation, plant RNA virus-mediated transformation, liposome- mediated transformation, transformation using wounded or enzyme-degraded immature embryos, or wounded or enzyme-degraded embryogenic callus and other methods known in the art.
- the vectors used in the method of the invention may contain further functional elements, for example "left border”- and “right border”-sequences of the T-DNA of Agrobacterium which allow for stably integration into the plant genome.
- methods and vectors are known to the person skilled in the art which permit the generation of marker free transgenic plants, i.e. the selectable or scorable marker gene is lost at a certain stage of plant development or plant breeding. This can be achieved by, for example co-transformation (Lyznik, Plant Mol. Biol. 13 (1989), 151-161 ; Peng, Plant Mol. Biol.
- Suitable strains of Agrobacterium tumefaciens and vectors as well as transformation of Agrobacteria and appropriate growth and selection media are well known to those skilled in the art and are described in the prior art (GV3101 (pMK90RK), Koncz, Mol. Gen. Genet. 204 (1986), 383-396; C58C1 (pGV 3850kan), Deblaere, Nucl. Acid Res. 13 (1985), 4777; Bevan, Nucleic. Acid Res. 12(1984), 8711 ; Koncz, Proc. Natl. Acad. Sci. USA 86 (1989), 8467- 8471 ; Koncz, Plant Mol. Biol.
- Agrobacterium tumefaciens is preferred in the method of the invention
- other Agrobacterium strains such as Agrobacterium rhizogenes
- Methods for the transformation using biolistic methods are well known to the person skilled in the art; see, e.g., Wan, Plant Physiol. 104 (1994), 37-48; Vasil, Bio/Technology 11 (1993), 1553-1558 and Christou (1996) Trends in Plant Science 1 , 423-431. Microinjection can be performed as described in Potrykus and Spangenberg (eds.), Gene Transfer To Plants. Springer Verlag, Berlin, NY (1995).
- Plants may also be transformed by an in planta method using Agrobacterium tumefaciens such as that described by Bechtoid et al, (1993) or Clough et al (1998), wherein A. tumefaciens is applied to the outside of the developing flower bud and the binary vector DNA is then introduced to the developing microspore and/or macrospore and/or the developing seed, so as to produce a transformed seed without the exogenous application of cytokinin and/or gibberellin.
- Agrobacterium tumefaciens such as that described by Bechtoid et al, (1993) or Clough et al (1998), wherein A. tumefaciens is applied to the outside of the developing flower bud and the binary vector DNA is then introduced to the developing microspore and/or macrospore and/or the developing seed, so as to produce a transformed seed without the exogenous application of cytokinin and/or gibberellin.
- transformation refers to the transfer of an exogenous polynucleotide into a host cell, irrespective of the method used for the transfer.
- the polynucleotide may be transiently or stably introduced into the host cell and may be maintained non-integrated, for example, as a plasmid, or alternatively, may be integrated into the host genome.
- the resulting transformed plant cell or plant tissue can then be used to regenerate a transformed plant in a manner known by a skilled person.
- the plants which can be modified according to the invention and which either show overexpression of a cell cycle complex according to the invention can be derived from any desired plant species. They can be monocotyledonous plants or dicotyledonous plants, preferably they belong to plant species of interest in agriculture, wood culture or horticulture interest, such as a crop plant, root plant, oil producing plant, wood producing plant, agricultured bioticultured plant, fodder or forage legume, companion plant, or horticultured plant e.g., such a plant is wheat, barley, maize, rice, carrot, sugar beet, cichorei, cotton, sunflower, tomato, cassava, grapes, soybean, sugar cane, flax, oilseed rape, tea, canola, onion, asparagus, carrot, celery, cabbage, lentil, broccoli, cauliflower, brussel sprout, artichoke, okra, squash, kale, collard greens or potato.
- a plant is wheat, barley, maize, rice, carrot, sugar be
- the present invention also relates to transgenic plants and plant tissue comprising transgenic plant cells according to the invention. Due to the (over)expression of the protein complex of the invention, e.g., at developmental stages and/or in plant tissue in which they do not naturally occur or are present at low levels, these transgenic plants may show various growth, yield or architectural modifications in comparison to wild-type plants.
- the present invention relates to a transgenic plant cell displaying de novo expressed cell cycle interacting protein complex or an increased amount of said complex compared to a corresponding wild type plant cell.
- Said transgenic plant cell comprises at least one nucleic acid molecule or regulatory sequence as defined above or obtainable by the method of the present invention.
- the present invention relates to transgenic plants and plant tissue obtainable by the method of the present invention.
- said transgenic plants may display various idiotypic modifications, preferably display modified and/or accelerated and/or enhanced plant growth, root growth and/or yield compared to the corresponding wild type plant.
- Preferred characteristics of the transgenic plants in the present invention is for example that the displays and increased cell division rate.
- the present invention contemplates the broad application of the inventive method to the modification of a range of cellular processes, including but not limited to the initiation, promotion, stimulation or enhancement of cell division, seed development, tuber formation, shoot initiation, leaf initiation, root growth, the inhibition of apical dominance etc.
- Any transformed plant obtained according to the invention can be used in a conventional breeding scheme or in in vitro plant propagation to produce more transformed plants with the same characteristics and/or can be used to introduce the same characteristic in other varieties of the same or related species. Such plants are also part of the invention. Seeds obtained from the transformed plants genetically also contain the same characteristic and are part of the invention.
- the present invention is in principle applicable to any plant and crop that can be transformed with any of the transformation method known to those skilled in the art and includes for instance corn, wheat, barley, rice, oilseed crops, cotton, tree species, sugar beet, cassava, tomato, potato, numerous other vegetables or fruits.
- the invention also relates to harvestable parts and to propagation material of the transgenic plants according to the invention which either contain transgenic plant cells over-expressing the protein complex according to the invention.
- Harvestable parts can be in principle any useful parts of a plant, for example, flowers, pollen, seedlings, tubers, leaves, stems, fruit, seeds, roots etc.
- Propagation material includes, for example, seeds, fruits, cuttings, seedlings, tubers, rootstocks etc.
- the present invention relates to the use of the above described nucleic acid molecules, regulatory sequences, and vectors for increasing cell division rates in plants, plant cells or plant tissue.
- said increased cell division rates result in increased biomass, plant growth, root and/or shoot growth, increased seed setting.
- said increased cell division rates result in increased plant growth, modified architecture and/or yield, e.g. of harvestable material, which is displayed for instance by (but not limited to) increased or enhanced biomass, root growth, shoot growth, seed set, seed production, grain yield, fruit size, nitrogen fixing capacity, nodule size, tuber formation, stem thickness, endosperm size, number of fruit per plant etc.
- the method of the present invention provides plant cells, plant tissue and plants with novel phenotypes due to the increased or de novo formation of complexes of cell cycle interacting proteins.
- the plants, plant tissue and plant cells of the present invention will allow the understanding of function of cell cycle protein complexes during this cell division may also open up the way for finding compounds that interfere with formation of such complexes.
- the present invention provide a basis for the development of mimetic compounds that may be inhibitors or regulators of cell cycle interacting proteins or their encoding genes. It will be appreciated that the present invention also provides cell based screening methods that allow a high-throughput-screening (HTS) of compounds that may be candidates for such inhibitors and regulators.
- HTS high-throughput-screening
- the present invention relates to a composition
- a composition comprising the nucleic acid molecule, the plant cell or the vector of the present invention or the mentioned vector comprised in the composition of the present invention or the mentioned nucleic acid molecules or regulatory sequences.
- the present invention relates to the use of the mentioned nucleic acid molecule or the mentioned regulatory sequence or the nucleic acid molecule, the vector or the plant cell of the present invention or the mentioned vectors of the composition of the present invention for the production of more biomass, of secondary metabolites or additives for plant culturing in plant cell culture.
- FIG. 1 Southern blots of the wild type (C24), and transgenic CycB1;1 overexpressing A. thaliana lines (Cyc 28.10 and Cyc 5.9). Genomic DNA extracted from C24, Cyc 28.10 and Cyc 5.9 was digested with the indicated enzymes, separated on a 3% agarose gel and blotted. The membranes are hybridised with a probe derived from the CycB1 ;1 cDNA at high stringency.
- RNA gel blot analysis RNA was extracted from control plants (C24), homozygous Cyc 5.9 plants, homozygous Cyc 28.10 plants, and heterozygous Cyc 5.9 x CDC2aAt plants. 20 ⁇ g of RNA was separated on a 0.8% agarose gel and blotted on a nitro-cellulose membrane. Equal loading was confirmed by methylene blue staining. The biot was hybridised using an antisense CYCB1 ;1 probe.
- the filters were probed using a CYCB1 ;1 (diluted 1/500) or a CDC2aAt (diluted 1/5000) specific antibody.
- a CYCB1 ;1 diluted 1/500
- a CDC2aAt diluted 1/5000 specific antibody.
- second antibody an anti-rabbit antibody coupled to peroxidase was used (diluted 1/10000). The detection was performed using the chemoluminescent procedure (Pierce, Rockford, IL).
- Root elongation rates as a function of time after sowing. Genotypes are indicated as in Fig 4. Data are averages ⁇ SE (n 8 -13) from the same roots as in Fig 4.
- Seeds of wild type A. thaliana (C24) and all transgenic lines are harvested from plants growing in the same conditions (22 °C and continuous light: 110 ⁇ E nr ⁇ 2 s "1 PAR) and stored at 4°C after harvesting from completely dried plants. For each line to be tested the following screens were performed comparing wild-type and transgenic.
- the position of the tip of the main root was marked daily at the bottom of the plate with a razorblade.
- the plates were digitised using a flatbed scanner with overhead illumination attached to a PC. Files with a resolution of 9.775 pixels per mm were saved in Tiff format.
- Root elongation rate for each root as a function of time was determined by dividing daily growth by the time interval between successive marks.
- cortical cell length was determined over the whole growth zone. Using the same setup as for the mature cell length, a series of partially overlapping images was recorded covering the whole of the growth zone and part of the mature region. Each series was transformed into a single composite image, which was then used to measure the length of all cells in each cortical file, starting from the quiescent centre. These data were transformed to express the length of each cell as a function of its midpoint. Interpolation and smoothing of these data was performed with a specially created algorithm, which repeatedly fits polynomials to small sections of the data to estimate the midpoint of such section (Beemster and Baskin, 1998). Data obtained with this algorithm are equidistally spaced and were averaged between replicate roots. All data processing was done using the spreadsheet program Excel (Microsoft Corporation). This procedure gives, in addition to the mature cell length, also an idea about size of meristematic cells, and size of the meristem.
- Total leaf (shoot) area was determined from the scanned images of the root systems described above. This was done by thresholding the image so as to select the entire shoot of each plantlet and then using the "analysis particles" routine. Obtained area values contain both leaf blade, petiole and hypocotyl. They are an underestimation for the true value of the area of these parts as the blades are aligned randomly instead of parallel to the field of view and there is overlap between various plant parts. It is obvious that the degree of underestimation increases for larger plants (more and larger organs) and therefore observed differences between genotypes are a conservative estimation of the true magnitude of differences in leaf area.
- Plants are germinated on agar as in Screen 1 , transferred to soil at two weeks and all seeds are harvested when the plants have completely dried. For each plant the total seed weight is then determined. Finally seed size is determined by placing between 100 and 300 seeds per parental plant on the flatbedscanner. Images are scanned at 2400 dpi and analysed using the program Photoshop with a set of additional image analysis plug-ins (The image processing toolkit version 3.0, Reindeer Games, Inc). The procedure is as follows: First the image is thresholded to select the seeds. Then touching seeds are separated using the watershed routine. After that all size/shape parameters are determined using the features/measure all command. From the resulting file the columns containing area, length, breadth, formfactor and roundness are selected. Outliers (dust and contamination particles) are removed based on their deviating formfactor and roundness factor. Of the remaining seeds the distribution is plotted and mean, median, average, standard deviation and standard error of the mean are determined.
- Vector pcyc1T735 gift of Dr. Paulo Ferreira, Departemento de Bioquimica Medica, UFRJ, Rio de Janeiro, Brazil
- a PUC 19 vector containing 1.2Kb CYCB1;1 cDNA with a T7 leader peptide and a NOS terminator, was digested with the restriction enzymes Ncol and Xbal.
- the PGSC TCyd vector was mobilised by the helper plasmid pRK 2013 into Agrobacterium tumefasciens C58C1 RifR, harbouring the plasmid PGV 2260 (Deblaere, 1985).
- A. thaliana plants (ecotype C24) were then transformed by root transformation (Valvekens, 1988).
- Transgenic plants were selected on hygromycine containing media and later transferred to soil for optimal seed production.
- a segregation analysis of ten independent lines was performed in the F1 generation based on hygromycine resistance, and out of two parental lines with single locus insertion (1/4 segregation; line 5 and 28) two homozygous daughter lines (5.9 and 28.10) of the F2 generation were selected.
- Root growth and cell length distribution was determined using Screen 1 described above.
- Leaf (shoot) area was determined using Screen 2 described above.
- Variations in root elongation can be due to differences in cell expansion or cell division characteristics.
- the length distribution of cortical cells was analysed along the root. Typically small meristematic cells are found at the tip of the root. In both wild type and roots from F1 seedlings from the CYCB1;1 and CDC2a overexpressing lines this region is approximately 500 Dm long (Fig 6).
- a region of rapidly growing cells is located between approximately 500 and 1750 ⁇ m from the quiescent centre of the root for both genotypes. Basal to 1750 ⁇ m, cells have reached their mature cell size. Given the small sample size of 2 roots per genotype and the large standard errors for the F1 line, it is uncertain if the observed differences in cell size are real.
- the area of the shoot in lateral projection mirrors the differences found in root growth (cf. Figs 3 and 6). Although only a rough measure for shoot area, these data indicate that the growth increase in the CYCB1;1 and CDC2a overexpressing lines is not restricted to the roots, but also occurs in the aerial parts of the plant.
- Example 3 In order to establish that the observed growth enhancement is not dependent on the specific growth conditions utilised for Example 3, an experiment similar to Example 3 is performed, but with a day/night cycle of 8/16 hrs. In addition to this, leaf growth under natural light conditions on soil (natural light intensity is too high for root growth) is investigated. For this, seeds of the same crosses as used in Example 3 are sown directly into potting soil and placed in glasshouse. Leaf area are measured at 1 weekly intervals from 5 representative plants of each cross. For this the leaf blades are dissected and placed on a flatbed scanner, which make a digital image of the leaves. Total leaf area is determined for each plant by measuring the combined blade area's using the thresholding option of the image analysis program Scion Image.
- transgenic plants e.g. Cdc2b and CycA
- media with 0.5X NaCl - thus providing an environmental stress or more particularly a salt stress.
- the response of the transgenic plants to this stress condition are assessed using the various Screens described previously.
- the template is total RNA isolated from a rice IR 52 cell suspension culture (Lee et al. 1989) that has been previously reversed transcribed as a bulk.
- the PCR conditions chosen to amplify this sequence are: 40 cycles of denaturation at 92° for 10 sec, annealing at 60° for 10 sec, extension at 72° for 60 sec. Concerning the oligos for cycOs2, they match ATGGAGAACATGAGATCTGA (SEQ ID NO:3) for the 5'end and TTACAGTGCCACGCTCTTGAG (SEQ ID NO:4) for the 3'side of the sequence.
- the expected size of the amplification product is 1259 bp.
- the following PCR conditions are used: 45 cycles of denaturation at 92° for 10 sec, annealing at 53° for 10 sec, and extension at 72° for 90 sec.
- the Pfu polymerase is used in both cases to generate blunt end fragments.
- the maize ubiquitin promoter from plasmid pAHC17 (Christensen, 1996) is excised as Pstl fragment (made blunt ended with Pfu polymerase) and subcloned into the Xbal site (filled-in) of the binary vector pBIBHYG to give the vector pBHU.
- the cDNA of cdc2Os-1 and cyclinOs2 are cloned into the Sacl site (trimmed off) of pPHU to produce pBHU-cdc2 and pBHU-cyc2.
- the vectors are then introduced into an Agrobacterium tumefaciens octopine strain, via electroporation (McCormac, 1998).
- A. tumefaciens bearing either pBHU-cdc2 or pBHU-cyc2 are used to produce transgenic rice expressing either cdc2Os-1 or cyclinOs2 under control of the ubiquitin promoter, following Hiei Y., (1994). Lines expressing highest levels of the transgenes are crossed to produce transgenic lines co-expressing both transgenes.
- transgenic rice plants overproducing both cdc20s-1 and cyclinOs2 will display increased growth rates and robustness. Since the growth stimulating effects observed in Arabidopsis have rather general character and not confined to a particular organ or tissue, we expect also the transgenic rice to show an increase in the grain size.
- Mutant alleles and wild type genes of CDC2bAt and CDC2fAt were cloned under the control of the CaMV 35S promoter and transferred to a binary vector.
- the CDC2bAt and CDC2fAt genes are cloned in a kanamycin- containing vector.
- the mutant alleles include dominant negative forms of CDKs (CDC2b.N161 and CDC2fAt.N164 - in both constructs the D residue was replaced with an N residue; this mutation has been shown to inactivate the kinase causing an arrest of the cell cycle) and positive forms of the CDKs.
- the following cyclin genes are cloned in a hygromycin vector allowing the coexpression of the cyciins and CDK combinations by crossing.
- Ncol and BamHl restriction sites were introduced in the cDNAs of CDC2bAt, CDC2bAt.A14F15 and CDC2bAt.N161 by performing PCRs with the following primers: 5'-GGCCATGGAGAAGTACGAGAAGC-3' (SEQ ID NO:5) (containing a Ncol restriction site) and 5'-
- Clal and Sail restriction sites were introduced in the cDNAs of CDC2fAt, CDC2fAt.A26F27 and CDC2fAt.N164 by performing PCRs with the following primers: 5'-GGATCGATATGGACGAGGGAGTTATAGC-3' (SEQ ID NO.7) (containing a Clal restriction site) and 5'-
- CYCA2;2 constructs in order to introduce the Clal and Sail restriction sites and a HA tag into the cDNAs of CYCA2;2 and CYCA2;2 ⁇ 64, PCRs were performed using the following primers:
- CYCA2;3 constructs in order to introduce the Sail restriction sites and a HA tag into the cDNAs of
- PCRs were performed using the following primers:
- the 3'NOS was removed from pH35S by BamHl and Xbal digestion and cloned into the BamHl and Xbal restriction sites of the vector pLBR19, resulting into the pLBR19/NOS vector.
- the obtained PCR fragments were cut with Sail and cloned into the Sail restriction site of pLBR19/NOS.
- the cassettes 35S-CYCA2;3-3'NOS and 35S- CYCA2;3 ⁇ 63-3'NOS were removed from pLBR19/NOS, blunt ended and cloned into the SNABI restriction site of the pGSC1704 binary vector.
- CYCB2;1 constructs in order to introduce the Sail and BamHl restriction sites and a HA tag into the cDNAs of CYCB2;1 and CYCB2;1 ⁇ 44, PCRs were be performed using the following primers:
- the obtained PCR fragments were cut with Sail and BamHl and cloned into the Sail and BamHl restriction sites of pLBR19/NOS.
- the cassettes 35S-CYCB2;1-3'NOS and 35S-CYCB2;1 ⁇ 44-3'NOS were removed from pLBR19/NOS, blunt ended and cloned into the SNABI restriction site of the pGSC1704 binary vector.
- CYCB-type ⁇ construct in order to introduce the Ncol and BamHl restriction sites and a HA tag into the cDNA of CYCB-type ⁇ , a PCR was performed using the following primers:
- GCGCCATGGGCTACCCTTACGATGTTCCAGATTACGCTCCACATATCCG TGATGAGG-3' (SEQ ID NO:18) (containing a Ncol site and a HA tag in fusion with the truncated CYCS-t pe-d), and 5'- GCGGATCCATTCTTCTCCCATTTTGG-3' (SEQ ID NO:19) (containing a BamHl restriction site).
- the PCR fragment was cut with Ncol and BamHl and cloned into the Ncol and BamHl sites of pH35S.
- the cassette 35S-CYCB-type ⁇ -3'NOS were removed from pH35S by EcoRl and BamHl digestion, blunt ended and cloned into the SNABI restriction site of the pGSC1704 binary vector.
- Transgenic plants are analysis for various growth and cell division characteristics or phenotypes according to the Screens described in the General Methodology above.
- the CDK containing fractions are first concentrated on DEAE 650S (TSK) therefore the pH is raised to 9.3 and the sample is applied onto the column (HR5/5 Pharmacia). Bound proteins are eluted in one step through injection of 0.5M NaCL in DEAE buffer (pH 7.8).
- the concentrated CDK fraction is further separated by size on a gel filtration column: Superdex 200pg Pharmacia (1.7x100cm column Omnifit) or a Sephacryl S200 Pharmacia (1.5x100cm column Pharmacia).
- the columns are equilibrated in S200 buffer when fractions (5ml) are collected or in DEAE buffer when the eluting proteins are immediately eluted onto DEAE 650S (TSK) (HR5/5 columns), in the latter case the pH of the size exclusion buffer was raised to 9.3 (cf. concentration step).
- CDK containing fractions (5ml) which are later bound on DEAE or those CDK complexes which are directly bound to DEAE when eluting from the size exclusion column are eluted in a similar way: a 10 column-volume gradient of 0-500mM NaCl is applied and the eluting complexes are collected.
- a final purification step consists of hydrophobic interaction chromatography: The conductivity of the purified fractions is raised tolOOmS by adding saturated ammonium sulphate and the samples are individually applied onto Ether PW-5 or Phenyl PW-5 (TSK). The bound complexes are eluted with a decreasing (NH 4 ) 2 S0 4 gradient and can be tested on their kinase activity.
- Cyclin A2:1 is present in a 100kDa complex with an as yet unidentified protein(s). However it is not yet clear whether the latter one is a CDC homologue or an (un)related protein.
- Plant cyciins A unified nomenclature for plant A-, B- and D-type cyciins based on sequence organisation. Plant Mol. Biol. 32, 1003-1018. Riou-Khamlichi C; Huntley R; Jacqmard A; Murray JA (1999) Cytokinin activation of Arabidopsis cell division through a D-type cyclin. Science
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU43960/00A AU4396000A (en) | 1999-03-19 | 2000-03-20 | Method for enhancing and/or improving plant growth and/or yield or modifying plant architecture |
EP00925126A EP1163341A2 (fr) | 1999-03-19 | 2000-03-20 | Procede pour accelerer et/ou ameliorer la croissance et/ou le rendement de vegetaux ou pour modifier leur architecture |
CA002367476A CA2367476A1 (fr) | 1999-03-19 | 2000-03-20 | Procede pour accelerer et/ou ameliorer la croissance et/ou le rendement de vegetaux ou pour modifier leur architecture |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99105671 | 1999-03-19 | ||
EP99105671.4 | 1999-03-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000056905A2 true WO2000056905A2 (fr) | 2000-09-28 |
WO2000056905A3 WO2000056905A3 (fr) | 2000-12-28 |
Family
ID=8237820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2000/002441 WO2000056905A2 (fr) | 1999-03-19 | 2000-03-20 | Procede pour accelerer et/ou ameliorer la croissance et/ou le rendement de vegetaux ou pour modifier leur architecture |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1163341A2 (fr) |
AU (1) | AU4396000A (fr) |
CA (1) | CA2367476A1 (fr) |
WO (1) | WO2000056905A2 (fr) |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001023594A2 (fr) * | 1999-09-27 | 2001-04-05 | Pioneer Hi-Bred International, Inc. | Amelioration de la tolerance au stress dans le mais par manipulation des genes de regulation du cycle cellulaire |
WO2002050292A2 (fr) * | 2000-12-08 | 2002-06-27 | Her Majesty In Right Of Canada As Represented By The Minister Of Agriculture And Agrifood Canada | Modulation d'activite d'inhibiteur de kinase dependante des cyclines (cdk) dans les plantes |
WO2003012035A2 (fr) * | 2001-07-27 | 2003-02-13 | Icon Genetics, Inc. | Usage commercial d'arabidopsis pour la production de proteines diagnostiques et therapeutiques humaines et animales |
WO2004087929A2 (fr) * | 2003-03-31 | 2004-10-14 | Cropdesign N.V. | Plantes a caracteristiques de croissance ameliorees et leur procede de production |
WO2005024029A3 (fr) * | 2003-09-05 | 2005-09-01 | Cropdesign Nv | Plantes a caracteristiques de croissance modifiees, et leur procede de production |
EP1580275A1 (fr) * | 2004-03-22 | 2005-09-28 | CropDesign N.V. | Plantes présentant des caractéristiques de croissance améliorée et procédé de fabrication associé |
WO2005093077A1 (fr) * | 2004-03-22 | 2005-10-06 | Cropdesign N.V. | Plantes presentant des caracteristiques de croissance ameliorees et leur procede de production |
WO2006013010A2 (fr) | 2004-07-31 | 2006-02-09 | Metanomics Gmbh | Preparation d'organismes a croissance plus rapide et/ou a meilleur rendement |
EP1711592A2 (fr) * | 2003-12-30 | 2006-10-18 | ArboGen, LLC | Genes de cycles cellulaires et leurs procedes d'utilisation associes |
WO2007141189A3 (fr) * | 2006-06-08 | 2008-02-14 | Basf Plant Science Gmbh | végétaux aux caractéristiques de croissance améliorées et procédé d'obtention |
WO2008138975A1 (fr) * | 2007-05-15 | 2008-11-20 | Cropdesign N.V. | ACCROISSEMENT DU RENDEMENT DE PLANTES PAR MODULATION DU ZmPKT |
US7589256B2 (en) | 2003-02-17 | 2009-09-15 | Metanomics Gmbh | Preparation of organisms with faster growth and/or higher yield |
US20090271895A1 (en) * | 2004-07-16 | 2009-10-29 | Cropdesign N.V. | Plants having improved growth characteristics and method for making the same |
WO2010023320A2 (fr) * | 2008-08-29 | 2010-03-04 | Basf Plant Science Company Gmbh | Végétaux présentant des caractéristiques associées au rendement améliorées, et leur procédé de production |
US7732663B2 (en) | 1998-06-08 | 2010-06-08 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food | Cyclin-dependent kinase inhibitors as plant growth regulators |
EP2272345A1 (fr) | 2009-07-07 | 2011-01-12 | Bayer CropScience AG | Processus d'amélioration de la croissance de semis et/ou levée précoce de cultures |
US20110145949A1 (en) * | 2008-08-20 | 2011-06-16 | Basf Plant Science Gmbh | Plants Having Enhanced Yield-Related Traits and a Method for Making the Same |
US8991098B2 (en) | 2008-09-16 | 2015-03-31 | Basf Plant Science Gmbh | Method for improved plant breeding |
US9538124B2 (en) | 2004-09-16 | 2017-01-03 | Cropdesign N.V. | Root evaluation |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1934259B (zh) * | 2004-03-22 | 2012-07-25 | 克罗普迪塞恩股份有限公司 | 具有改良的生长特性的植物以及制备所述植物的方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992009685A1 (fr) * | 1990-11-29 | 1992-06-11 | The Australian National University | Procede de regulation de la proliferation et de la croissance des cellules vegetales |
WO1997002354A1 (fr) * | 1995-06-30 | 1997-01-23 | Medical Research Council | INTERACTION DE LA PROTEINE p53 AVEC UN FACTEUR DE TRANSCRIPTION DP-1 |
WO1998003631A1 (fr) * | 1996-07-18 | 1998-01-29 | The Salk Institute For Biological Studies | Procede d'accroissement de la croissance et du rendement de plantes |
WO1998041642A1 (fr) * | 1997-03-14 | 1998-09-24 | Cropdesign N.V. | Procede et moyens de modulation des proteines du cycle cellulaire des plantes et utilisation de ces moyens pour controler la croissance cellulaire des plantes |
WO1999013083A2 (fr) * | 1997-09-05 | 1999-03-18 | Cropdesign N.V. | Methode et dispositif de modulation de proteines de cycle cellulaire vegetal et leur utilisation dans la regulation de la croissance de cellules vegetales |
WO1999058681A2 (fr) * | 1998-05-08 | 1999-11-18 | Consejo Superior De Investigaciones Cientificas | Cellules de plantes transgeniques exprimant un peptide e2f vegetal recombinant |
-
2000
- 2000-03-20 AU AU43960/00A patent/AU4396000A/en not_active Abandoned
- 2000-03-20 EP EP00925126A patent/EP1163341A2/fr not_active Withdrawn
- 2000-03-20 CA CA002367476A patent/CA2367476A1/fr not_active Abandoned
- 2000-03-20 WO PCT/EP2000/002441 patent/WO2000056905A2/fr not_active Application Discontinuation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992009685A1 (fr) * | 1990-11-29 | 1992-06-11 | The Australian National University | Procede de regulation de la proliferation et de la croissance des cellules vegetales |
WO1997002354A1 (fr) * | 1995-06-30 | 1997-01-23 | Medical Research Council | INTERACTION DE LA PROTEINE p53 AVEC UN FACTEUR DE TRANSCRIPTION DP-1 |
WO1998003631A1 (fr) * | 1996-07-18 | 1998-01-29 | The Salk Institute For Biological Studies | Procede d'accroissement de la croissance et du rendement de plantes |
WO1998041642A1 (fr) * | 1997-03-14 | 1998-09-24 | Cropdesign N.V. | Procede et moyens de modulation des proteines du cycle cellulaire des plantes et utilisation de ces moyens pour controler la croissance cellulaire des plantes |
WO1999013083A2 (fr) * | 1997-09-05 | 1999-03-18 | Cropdesign N.V. | Methode et dispositif de modulation de proteines de cycle cellulaire vegetal et leur utilisation dans la regulation de la croissance de cellules vegetales |
WO1999058681A2 (fr) * | 1998-05-08 | 1999-11-18 | Consejo Superior De Investigaciones Cientificas | Cellules de plantes transgeniques exprimant un peptide e2f vegetal recombinant |
Non-Patent Citations (7)
Title |
---|
DOONAN J: "PLANT GROWTH: ROOTS IN THE CELL CYCLE" CURRENT BIOLOGY,GB,CURRENT SCIENCE,, vol. 6, no. 7, 1 July 1996 (1996-07-01), pages 788-789, XP002045511 ISSN: 0960-9822 * |
FOWLER M R ET AL: "The plant cell cycle in context." MOLECULAR BIOTECHNOLOGY, vol. 10, no. 2, October 1998 (1998-10), pages 123-153, XP000939061 ISSN: 1073-6085 * |
FRANCIS DENNIS: "Regulation of the cell cycle plant development" BIOSIS, ACTA PHARMACEUTICA, vol. 45, no. 2, 1995, XP002140190 * |
GENSCHIK PASCAL ET AL: "Cell cycle-dependent proteolysis in plants: Identification of the destruction box pathway and metaphase arrest produced by the proteasome inhibitor MG132." PLANT CELL, vol. 10, no. 12, December 1998 (1998-12), pages 2063-2075, XP002146545 ISSN: 1040-4651 * |
RIOU-KHAMLICHI C ET AL: "Cytokinin activation of Arabidopsis cell division through a D-type cyclin" SCIENCE,US,AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, vol. 283, no. 5407, 5 March 1999 (1999-03-05), pages 1541-1544, XP002134537 ISSN: 0036-8075 cited in the application * |
SAUTER MARGRET: "Differential expression of a CAK (cdc2-activating kinase)-like protein kinase, cyclins and cdc2 genes from rice during the cell cycle and in response to gibberellin." PLANT JOURNAL, vol. 11, no. 2, 1997, pages 181-190, XP002146544 ISSN: 0960-7412 * |
SEGERS GERDA ET AL: "The Arabidopsis cyclin-dependent kinase gene cdc2bAt is preferentially expressed during S and G-2 phases of the cell cycle" PLANT JOURNAL,GB,BLACKWELL SCIENTIFIC PUBLICATIONS, OXFORD, vol. 10, no. 4, 1996, pages 601-612, XP002138663 ISSN: 0960-7412 cited in the application * |
Cited By (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7732663B2 (en) | 1998-06-08 | 2010-06-08 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food | Cyclin-dependent kinase inhibitors as plant growth regulators |
WO2001023594A2 (fr) * | 1999-09-27 | 2001-04-05 | Pioneer Hi-Bred International, Inc. | Amelioration de la tolerance au stress dans le mais par manipulation des genes de regulation du cycle cellulaire |
WO2001023594A3 (fr) * | 1999-09-27 | 2001-12-06 | Pioneer Hi Bred Int | Amelioration de la tolerance au stress dans le mais par manipulation des genes de regulation du cycle cellulaire |
WO2002050292A2 (fr) * | 2000-12-08 | 2002-06-27 | Her Majesty In Right Of Canada As Represented By The Minister Of Agriculture And Agrifood Canada | Modulation d'activite d'inhibiteur de kinase dependante des cyclines (cdk) dans les plantes |
WO2002050292A3 (fr) * | 2000-12-08 | 2002-09-19 | Ca Minister Agriculture & Food | Modulation d'activite d'inhibiteur de kinase dependante des cyclines (cdk) dans les plantes |
WO2003012035A2 (fr) * | 2001-07-27 | 2003-02-13 | Icon Genetics, Inc. | Usage commercial d'arabidopsis pour la production de proteines diagnostiques et therapeutiques humaines et animales |
WO2003012035A3 (fr) * | 2001-07-27 | 2005-05-19 | Icon Genetics Inc | Usage commercial d'arabidopsis pour la production de proteines diagnostiques et therapeutiques humaines et animales |
EP2322633A2 (fr) | 2003-02-17 | 2011-05-18 | Metanomics GmbH | Préparation d'organismes dotés d'une croissance plus rapide et/ou d'un meilleur rendement |
US7589256B2 (en) | 2003-02-17 | 2009-09-15 | Metanomics Gmbh | Preparation of organisms with faster growth and/or higher yield |
WO2004087929A2 (fr) * | 2003-03-31 | 2004-10-14 | Cropdesign N.V. | Plantes a caracteristiques de croissance ameliorees et leur procede de production |
US8299319B2 (en) | 2003-03-31 | 2012-10-30 | Cropdesign N.V. | Plants having improved growth characteristics and a method for making the same |
WO2004087929A3 (fr) * | 2003-03-31 | 2004-12-23 | Cropdesign Nv | Plantes a caracteristiques de croissance ameliorees et leur procede de production |
CN102174545A (zh) * | 2003-09-05 | 2011-09-07 | 作物培植股份有限公司 | 具有改变的生长特性的植物及其制备方法 |
CN102174545B (zh) * | 2003-09-05 | 2016-11-23 | 作物培植股份有限公司 | 具有改变的生长特性的植物及其制备方法 |
US20070199085A1 (en) * | 2003-09-05 | 2007-08-23 | Willem Broekaert | Plants Having Modified Growth Characteristics And Method For Making Same |
WO2005024029A3 (fr) * | 2003-09-05 | 2005-09-01 | Cropdesign Nv | Plantes a caracteristiques de croissance modifiees, et leur procede de production |
CN1845997B (zh) * | 2003-09-05 | 2012-07-25 | 作物培植股份有限公司 | 具有改变的生长特性的植物及其制备方法 |
AU2004270888B2 (en) * | 2003-09-05 | 2008-08-07 | Cropdesign N.V. | Plants having modified growth characteristics and method for making the same |
EP1711592A4 (fr) * | 2003-12-30 | 2007-08-22 | Arborgen Llc | Genes de cycles cellulaires et leurs procedes d'utilisation associes |
JP2011097941A (ja) * | 2003-12-30 | 2011-05-19 | Arborgen Inc | 細胞周期遺伝子および関連した使用方法 |
JP2007523636A (ja) * | 2003-12-30 | 2007-08-23 | アーバージェン リミテッド ライアビリティ カンパニー | 細胞周期遺伝子および関連した使用方法 |
US7598084B2 (en) | 2003-12-30 | 2009-10-06 | Arborgen Llc | Modifications of plant traits using cyclin A |
EP1711592A2 (fr) * | 2003-12-30 | 2006-10-18 | ArboGen, LLC | Genes de cycles cellulaires et leurs procedes d'utilisation associes |
WO2005093077A1 (fr) * | 2004-03-22 | 2005-10-06 | Cropdesign N.V. | Plantes presentant des caracteristiques de croissance ameliorees et leur procede de production |
US7579518B2 (en) | 2004-03-22 | 2009-08-25 | Cropdesign N.V. | Plants having improved seed yield and expressing a nucleic acid encoding a small subunit ribosomal (S3A) protein and method for making the same |
EP1580275A1 (fr) * | 2004-03-22 | 2005-09-28 | CropDesign N.V. | Plantes présentant des caractéristiques de croissance améliorée et procédé de fabrication associé |
US20090271895A1 (en) * | 2004-07-16 | 2009-10-29 | Cropdesign N.V. | Plants having improved growth characteristics and method for making the same |
WO2006013010A2 (fr) | 2004-07-31 | 2006-02-09 | Metanomics Gmbh | Preparation d'organismes a croissance plus rapide et/ou a meilleur rendement |
US9538124B2 (en) | 2004-09-16 | 2017-01-03 | Cropdesign N.V. | Root evaluation |
US8273952B2 (en) | 2006-06-08 | 2012-09-25 | Basf Plant Science Gmbh | Plants having improved growth characteristics and method for making the same |
WO2007141189A3 (fr) * | 2006-06-08 | 2008-02-14 | Basf Plant Science Gmbh | végétaux aux caractéristiques de croissance améliorées et procédé d'obtention |
EP2436760A1 (fr) * | 2006-06-08 | 2012-04-04 | BASF Plant Science GmbH | Installations dotées de caractéristiques de croissance améliorées et procédé de fabrication de celles-ci |
EP2436761A1 (fr) * | 2006-06-08 | 2012-04-04 | BASF Plant Science GmbH | Installations dotées de caractéristiques de croissance améliorées et procédé de fabrication de celles-ci |
WO2008138975A1 (fr) * | 2007-05-15 | 2008-11-20 | Cropdesign N.V. | ACCROISSEMENT DU RENDEMENT DE PLANTES PAR MODULATION DU ZmPKT |
US20110145949A1 (en) * | 2008-08-20 | 2011-06-16 | Basf Plant Science Gmbh | Plants Having Enhanced Yield-Related Traits and a Method for Making the Same |
WO2010023320A3 (fr) * | 2008-08-29 | 2010-05-20 | Basf Plant Science Company Gmbh | Végétaux présentant des caractéristiques associées au rendement améliorées, et leur procédé de production |
US20110214207A1 (en) * | 2008-08-29 | 2011-09-01 | Basf Plant Science Company Gmbh | Plants Having Enhanced Yield-Related Traits and a Method for Making the Same |
US8946512B2 (en) | 2008-08-29 | 2015-02-03 | Basf Plant Science Company Gmbh | Plants having enhanced yield-related traits and a method for making the same |
WO2010023320A2 (fr) * | 2008-08-29 | 2010-03-04 | Basf Plant Science Company Gmbh | Végétaux présentant des caractéristiques associées au rendement améliorées, et leur procédé de production |
US8991098B2 (en) | 2008-09-16 | 2015-03-31 | Basf Plant Science Gmbh | Method for improved plant breeding |
US10244692B2 (en) | 2008-09-16 | 2019-04-02 | BASF Plan Science GmbH | Method of improved plant breeding |
WO2011003533A2 (fr) | 2009-07-07 | 2011-01-13 | Bayer Cropscience Ag | Procédé permettant d'améliorer la croissance de semis et/ou l'émergence précoce de cultures |
EP2272345A1 (fr) | 2009-07-07 | 2011-01-12 | Bayer CropScience AG | Processus d'amélioration de la croissance de semis et/ou levée précoce de cultures |
Also Published As
Publication number | Publication date |
---|---|
WO2000056905A3 (fr) | 2000-12-28 |
EP1163341A2 (fr) | 2001-12-19 |
AU4396000A (en) | 2000-10-09 |
CA2367476A1 (fr) | 2000-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2005251653B2 (en) | The shine clade of transcription factors and their use | |
EP2422615B1 (fr) | Protection de protéines krp mutantes négatives dominantes d'inhibition active du complexe cycline/cdk par krp de type sauvage | |
EP1163341A2 (fr) | Procede pour accelerer et/ou ameliorer la croissance et/ou le rendement de vegetaux ou pour modifier leur architecture | |
CA2695929C (fr) | Gene regulateur de la hauteur d'une plante et ses utilisations | |
US9809827B2 (en) | Transgenic maize | |
US20120115230A1 (en) | Phenylpropanoid related regulatory protein-regulatory region associations | |
AU2015327578A1 (en) | New rice high temperature resistance gene and use in crop breeding resistance to high temperature thereof | |
US20150128304A1 (en) | Plant Body Showing Improved Resistance Against Environmental Stress and Method for Producing Same | |
US10487337B2 (en) | Methods for monocot plant improvement | |
WO2007148970A1 (fr) | Utilisation de gènes de remodelage de la chromatine des végétaux pour moduler l'architecture et la croissance des végétaux | |
Lu et al. | Isolation and expression analysis of a LEAFY/FLORICAULA homolog and its promoter from London plane (Platanus acerifolia Willd.) | |
US20160102316A1 (en) | Stress tolerant plants | |
US20190359996A1 (en) | Transcription factor genes and proteins from helianthus annuus, and transgenic plants including the same | |
CN114591409B (zh) | TaDTG6蛋白在提高植物抗旱性中的应用 | |
US8461414B2 (en) | Gene having endoreduplication promoting activity | |
WO2014083301A1 (fr) | Plantes transgéniques avec une sumoylation altérée | |
WO2001031041A2 (fr) | Modification de vegetaux | |
JP2001520887A (ja) | 新規な分裂促進性サイクリンおよびその使用 | |
US9758790B2 (en) | Modulating the level of components within plants | |
CN111205355B (zh) | 植物耐逆性相关蛋白SiWRKY76及其编码基因与应用 | |
Rubio et al. | Stress tolerant plants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
ENP | Entry into the national phase |
Ref document number: 2367476 Country of ref document: CA Ref country code: CA Ref document number: 2367476 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000925126 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000925126 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09937008 Country of ref document: US |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000925126 Country of ref document: EP |